Document:

Exhibit 10.4

 

EMPLOYMENT
AGREEMENT

between

GULFPORT
ENERGY CORPORATION

and

Michael
Sluiter

Effective
November 13, 2020

 

EMPLOYMENT
AGREEMENT

 

THIS
AGREEMENT is made effective November 13, 2020 (the “Effective Date”), between GULFPORT ENERGY CORPORATION, a
Delaware corporation (the “Company”) and Michael Sluiter, an individual (the “Executive”).

 

W
I T N E S S E T H:

 

WHEREAS,
the Company desires to retain the services of the Executive and the Executive desires to make the Executive’s services available
to the Company.

 

NOW,
THEREFORE, in consideration of the mutual promises herein contained, the Company and the Executive agree as follows:

 

		1.	Employment.
                                         The Company hereby employs the Executive and the Executive hereby accepts such employment
                                         subject to the terms and conditions contained in this Agreement.

 

		2.	Executive’s
                                         Duties. The Executive is employed on a full-time basis. Throughout the term of this
                                         Agreement, the Executive will use the Executive’s best efforts and due diligence
                                         to assist the Company in achieving the most profitable operation of the Company and the
                                         Company’s affiliated entities consistent with developing and maintaining a quality
                                         business operation.

 

		2.1	Specific
                                         Duties. The Executive will serve as Senior Vice President, Reservoir Engineering
                                         for the Company, and in such other positions as might be mutually agreed upon by the
                                         parties. The Executive shall perform all of the duties required to fully and faithfully
                                         execute the office and position to which the Executive is appointed, and such other duties
                                         as may be reasonably requested by the Executive’s supervisor or by the Company.
                                         During the term of this Agreement, the Executive may be nominated for election or appointed
                                         to serve as a director or officer of any of the Company’s affiliated entities as
                                         determined in such affiliates’ board of directors’ sole discretion. The services
                                         of the Executive will be requested and directed by the Company’s Chief Operating
                                         Officer, Donnie Moore.

 

		2.2	Duty
                                         of Loyalty. The Executive acknowledges and agrees that the Executive has a fiduciary
                                         duty of loyalty to act in the best interests of the Company and to do no act that would
                                         materially injure the business, interests or reputation of the Company or any of its
                                         affiliates. In keeping with these duties, the Executive shall make full disclosure to
                                         the Company of all business opportunities pertaining to the Company’s business
                                         and shall not appropriate for the Executive’s own benefit business opportunities
                                         concerning the subject matter of the fiduciary relationship.

 

    

     

    

 

		2.3	Policies
                                         and Procedures. The Company has issued various policies and procedures applicable
                                         to all employees of the Company and its related and affiliated entities including policies
                                         which set forth the general human resources policies of the Company and addresses frequently
                                         asked questions regarding the Company. The Executive agrees to comply with such policies
                                         and procedures except to the extent inconsistent with this Agreement. Such policies and
                                         procedures may be changed or adopted in the sole discretion of the Company without advance
                                         notice.

 

		3.	Other
                                         Activities. The Executive shall devote substantially all of the Executive’s
                                         business time and attention to the performance of the Executive’s duties hereunder
                                         and will not engage in any other business, profession, or occupation for compensation
                                         or otherwise which would conflict with the performance of such services either directly
                                         or indirectly without the prior written consent of the Board of Directors of the Company
                                         (the “Board”). Notwithstanding the foregoing, the Executive will be permitted
                                         to (a) with the prior written consent of the Board, act or serve as a director, trustee,
                                         committee member, or principal of any type of business, civic, or charitable organization,
                                         and (b) purchase or own less than five percent (5%) of the publicly traded securities
                                         of any corporation; provided that, such ownership represents a passive investment and
                                         that the Executive is not a controlling person of, or a member of a group that controls,
                                         such corporation; provided further that, the activities described in clauses (a) and
                                         (b) do not interfere with the performance of the Executive’s duties and responsibilities
                                         to the Company as provided hereunder, including, but not limited to, the obligations
                                         set forth in Section 2.

 

		4.	Executive’s
                                         Compensation. The Company agrees to compensate the Executive as follows:

 

		4.1	Base
                                         Salary. A base salary (the “Base Salary”), at the initial annual rate
                                         of not less than $360,000 (temporarily reduced to an annual rate of $324,000 through
                                         December 31, 2020) will be paid to the Executive in regular installments in accordance
                                         with the Company’s designated payroll schedule.

 

		4.2	Bonus.
                                         In addition to the Base Salary described in Section 4.1 of this Agreement, the Executive
                                         shall be eligible for an annual bonus for each fiscal year during the Term on the same
                                         basis as other executive officers under the Company’s then current annual incentive
                                         plan with a target of 60% of Base Salary which shall be payable in accordance with the
                                         terms of such plan and the performance metrics established by the Compensation Committee
                                         of the Board (the “Committee”).

 

		4.3	Equity
                                         Compensation. During the term of the Executive’s employment, the Executive
                                         will be eligible for annual grants of restricted stock, restricted stock units, performance-
                                         based awards, stock options or other awards as determined in the sole discretion of the
                                         Committee in its discretion pursuant to the Company’s equity compensation plans
                                         (generally referred to as “Equity Compensation Plans”), subject to the terms
                                         and conditions of the Equity Compensation Plans and the terms and conditions of each
                                         award as determined by the Committee in its discretion. The target aggregate fair value
                                         of such awards shall be as determined by the Committee in its discretion, it being understood
                                         that the Committee may elect to not provide the Executive an award with respect to a
                                         particular year.

 

    2

     

    

 

		4.4	Benefits.
                                         The Company will provide the Executive with benefits that are customarily provided to
                                         similarly situated executives of the Company and as are set forth in and governed by
                                         the Company’s employment policies and applicable plan documents. Additionally,
                                         the Company will provide paid time off (“PTO”) to the Executive, the amount
                                         of which will be determined in accordance with the Company’s PTO policy. No additional
                                         compensation will be paid for failure to take PTO. The Company will also provide the
                                         Executive the opportunity to apply for coverage under the Company’s medical, life
                                         and disability plans, if any. If the Executive is accepted for coverage under such plans,
                                         the Company will make such coverage available to the Executive on the same terms as is
                                         customarily provided by the Company to the plan participants as modified from time to
                                         time in the Company’s sole discretion. The Executive will be entitled to receive
                                         reimbursement for all reasonable business expenses incurred by the Executive in accordance
                                         with the Company’s expense reimbursement policy. All payments for reimbursement
                                         under this Section 4.4 shall be paid promptly but in no event later than the last day
                                         of the Executive’s taxable year following the taxable year in which the Executive
                                         incurred such expenses.

 

		5.	Term.
                                         The term of the Executive’s employment under the provisions of this Agreement shall
                                         be for a period commencing on the Effective Date and shall continue until December 31,
                                         2023 (the “Initial Expiration Date”), unless terminated earlier pursuant
                                         to Section 6; provided that, upon the Initial Expiration Date and each annual anniversary
                                         thereafter (such date and each annual anniversary thereof, a “Renewal Date”),
                                         the Agreement shall be deemed to be automatically extended, upon the same terms and conditions,
                                         for successive periods of one year, unless either party provides written notice of its
                                         intention not to extend the term of the Agreement at least ninety (90) days prior to
                                         the applicable Renewal Date (the period of the Executive’s employment under this
                                         Agreement being the “Term”); provided, however, if during the Term of this
                                         Agreement a Change of Control (as defined in Exhibit A attached hereto) occurs, the Term
                                         of this Agreement shall be extended to the later of the original expiration date of the
                                         Term or the expiration of the Change of Control Period. For purposes of this Agreement,
                                         “Change of Control Period” means the twenty-four (24) month period commencing
                                         on the effective date of a Change of Control.

 

		6.	Termination.
                                         This Agreement will continue in effect until the expiration of the term stated in Section
                                         5 of this Agreement unless earlier terminated pursuant to this Section 6. For purposes
                                         of this Agreement, “Termination Date” shall mean (a) if the Executive’s
                                         employment is terminated by death, the date of death; (b) if the Executive’s employment
                                         is terminated pursuant to Section 6.4 due to a disability, thirty (30) days after notice
                                         of termination is provided to the Executive in accordance with Section 6.4; (c) if the
                                         Executive’s employment is terminated by Company without Cause or by the Executive
                                         for Good Reason pursuant to Section 6.1.1 or 6.1.2, on the effective date of termination
                                         specified in the notice required by Section 6.1.1 or 6.1.2 respectively; (d) if the Executive’s
                                         employment is terminated by Company for Cause pursuant to Section 6.1.3, the date on
                                         which the notice of termination required by Section 6.1.3 is given; or (e) if the Executive’s
                                         employment is terminated by the Executive pursuant to Section 6.2, on the effective date
                                         of termination specified by the Executive in the notice of termination required by Section 6.2
                                         unless the Company rejects such date as allowed by Section 6.2, in which case it would
                                         be the date specified by the Company.

 

    3

     

    

 

		6.1	Termination
                                         by Company. The Executive’s employment under this Agreement may be terminated
                                         prior to the expiration of the Term under the following circumstances:

 

		6.1.1	Termination
                                         without Cause or for Good Reason Outside of a Change of Control Period.

 

		a)	Termination
                                         by the Company without Cause. The Company may terminate the Executive’s employment
                                         without Cause at any time by the service of written notice of termination to the Executive
                                         specifying an effective date of such termination not sooner than the date of such notice.

 

		b)	Termination
                                         by the Executive for Good Reason. The Executive may terminate employment with the
                                         Company for “Good Reason” and such termination will not be a breach of this
                                         Agreement by the Executive. For purposes of this Section 6.1.1(b), Good Reason shall
                                         mean the occurrence of one of the events set forth below:

 

		(i)	elimination
                                         of the Executive’s job position or material reduction in duties and/or reassignment
                                         of the Executive to a new position of materially less authority; or

 

		(ii)	a
                                         material reduction in the Executive’s Base Salary.

 

Notwithstanding
the foregoing, the Executive will not be deemed to have terminated for Good Reason unless (A) the Executive provides written notice
to the Company of the existence of one of the conditions described above within ninety (90) days after the Executive has knowledge
of the initial existence of the condition, (B) the Company fails to remedy the condition so identified within thirty (30) days
after receipt of such notice (if capable of correction), (C) the Executive provides a notice of termination to the Company within
thirty (30) days of the expiration of the Company’s period to remedy the condition specifying an effective date for the
Executive’s termination, and (D) the effective date of the Executive’s termination of employment is within ninety
(90) days after the Executive provides written notice to the Company of the existence of the condition referred to in clause (A).

 

    4

     

    

 

		c)	Obligations
                                         of the Company. In the event the Executive is Terminated without Cause or terminates
                                         employment for Good Reason outside of a Change of Control Period, the Executive will
                                         receive as termination compensation on the date sixty (60) days following the Termination
                                         Date: (a) a payment of one (1) times the sum of Base Salary and Annual Bonus in a lump
                                         sum payment; (b) a payment of the pro-rata portion of the Annual Bonus for the fiscal
                                         year in which the Termination Date occurs determined based on the number of days that
                                         have lapsed during the calendar year prior to the Termination Date divided by 365; (c)
                                         pro rata vesting through the last day of the month in which the Termination Date occurs
                                         of all unvested awards granted to the Executive under the Equity Compensation Plans (provided
                                         performance-based restricted stock units shall only be payable subject to the attainment
                                         of the performance measures through the Termination Date (or the most recent practicable
                                         date) as provided under the terms of the applicable award agreement); (d) any Company
                                         matching or other contributions to the Company’s non-qualified deferred compensation
                                         plans, if any, (the “Company Non-Qualified Contributions”) shall be immediately
                                         vested; (e) a lump sum payment of any PTO pay accrued but unused through the Termination
                                         Date and (f) a lump sum payment equal to the Executive’s monthly COBRA premium
                                         for a twelve (12) month period. For purposes of this Agreement “Annual Bonus”
                                         shall be defined as the Executive’s target bonus for the year in which the Termination
                                         Date occurs. The right to the foregoing termination compensation described under clauses
                                         (a), (b), (c) and (d) above is subject to the Executive’s timely execution, without
                                         revocation, of the Company’s waiver and release agreement substantially in the
                                         form attached hereto as “Exhibit B” which will operate as a release of all
                                         legally waivable claims against the Company and the Executive’s compliance with
                                         all of the provisions of this Agreement, including all post-employment obligations.

 

		6.1.2	Termination
                                         without Cause or for Good Reason During a Change of Control Period. Notwithstanding
                                         the foregoing, the Executive will not be deemed to have terminated for Good Reason unless
                                         (A) the Executive provides written notice to the Company of the existence of one of the
                                         conditions described above within ninety (90) days after the Executive has knowledge
                                         of the initial existence of the condition, (B) the Company fails to remedy the condition
                                         so identified within thirty (30) days after receipt of such notice (if capable of correction),
                                         (C) the Executive provides a Notice of Termination to the Company within thirty (30)
                                         days of the expiration of the Company’s period to remedy the condition specifying
                                         an effective date for the Executive’s termination, and (D) the effective date of
                                         the Executive’s termination of employment is within ninety (90) days after the
                                         Executive provides written notice to the Company of the existence of the condition referred
                                         to in clause (A).

 

		a)	Termination
                                         by the Company without Cause. The Company may terminate the Executive’s employment
                                         without Cause during a Change of Control Period at any time by the service of written
                                         notice of termination to the Executive specifying an effective date of such termination
                                         not sooner than the date of such notice.

 

    5

     

    

 

		b)	Termination
                                         by the Executive for Good Reason. The Executive may terminate employment with the
                                         Company for “Good Reason” and such termination will not be a breach of this
                                         Agreement by the Executive. For purposes of this Section 6.1.2(b), Good Reason during
                                         a Change of Control Period shall mean the occurrence of one of the events set forth below:

 

		(i)	elimination
                                         of the Executive’s job position or material reduction in duties and/or reassignment
                                         of the Executive to a new position of materially less authority;

 

		(ii)	a
                                         material reduction in the Executive’s Base Salary; or

 

		(iii)	a
                                         requirement that the Executive relocate to a location outside of a fifty (50) mile radius
                                         of the location of his or her office or principal base of operation immediately prior
                                         to the effective date of a Change of Control.

 

Notwithstanding
the foregoing, the Executive will not be deemed to have terminated for Good Reason unless (A) the Executive provides written notice
to the Company of the existence of one of the conditions described above within ninety (90) days after the Executive has knowledge
of the initial existence of the condition, (B) the Company fails to remedy the condition so identified within thirty (30) days
after receipt of such notice (if capable of correction), (C) the Executive provides a notice of termination to the Company within
thirty (30) days of the expiration of the Company’s period to remedy the condition specifying an effective date for the
Executive’s termination, and (D) the effective date of the Executive’s termination of employment is within ninety
(90) days after the Executive provides written notice to the Company of the existence of the condition referred to in clause (A).

 

		c)	Obligations
                                         of the Company. In the event the Executive is Terminated without Cause or terminates
                                         employment for Good Reason during a Change of Control Period, the Executive will receive
                                         as termination compensation on the date sixty (60) days following the Termination Date:
                                         (a) a payment of one (1) times the sum of Base Salary and Annual Bonus in a lump sum
                                         payment; (b) a payment of the pro-rata portion of the Annual Bonus for the fiscal year
                                         in which the Termination Date occurs determined based on the number of days that have
                                         lapsed during the calendar year prior to the Termination Date divided by 365; (c) all
                                         unvested awards granted under the Equity Compensation Plans shall be immediately vested
                                         (provided performance-based restricted stock units shall only be payable subject to the
                                         attainment of the performance measures through the Termination Date (or the most recent
                                         practicable date) as provided under the terms of the applicable award agreement); (d)
                                         any Company Non-Qualified Contributions shall be immediately vested; (e) a lump sum payment
                                         of any PTO pay accrued but unused through the Termination Date and (f) a lump sum payment
                                         equal to the Executive’s monthly COBRA premium for an eighteen (18) month
                                         period. The right to the foregoing termination compensation described under clauses (a),
                                         (b), (c) and (d) above is subject to the Executive’s timely execution, without
                                         revocation, of the Company’s waiver and release agreement substantially in the
                                         form attached hereto as “Exhibit B” which will operate as a release of all
                                         legally waivable claims against the Company and the Executive’s compliance with
                                         all of the provisions of this Agreement, including all post-employment obligations.

 

    6

     

    

 

		6.1.3	Termination
                                         for Cause. The Company may terminate the employment of the Executive hereunder at
                                         any time for Cause (as hereinafter defined) (such a termination being referred to in
                                         this Agreement as a “Termination For Cause”) by giving the Executive written
                                         notice of such termination. As used in this Agreement, “Cause” means:

 

In
the event this Agreement is terminated for Cause, the Company will not have any obligation to provide any further payments or
benefits to the Executive after the Termination Date other than a lump sum payment within thirty (30) days of the Termination
Date of any PTO pay accrued but unused through the Termination Date.

 

		(i)	the
                                         willful and continued failure of the Executive to perform substantially the Executive’s
                                         duties with the Company or one of its affiliates (other than any such failure resulting
                                         from incapacity due to physical or mental illness), after a written demand for substantial
                                         performance is delivered to the Executive by the Board or the Chief Executive Officer
                                         of the Company which specifically identifies the manner in which the Board or Chief Executive
                                         Officer believes that the Executive has not substantially performed the Executive’s
                                         duties, or

 

		(ii)	the
                                         willful engaging by the Executive in illegal conduct or gross misconduct which is materially
                                         and demonstrably injurious to the Company. For purposes of this provision, no act, or
                                         failure to act, on the part of the Executive shall be considered “willful”
                                         unless it is done, or omitted to be done, by the Executive in bad faith or without reasonable
                                         belief that the Executive’s action or omission was in the best interests of the
                                         Company. Any act, or failure to act, based upon authority given pursuant to a resolution
                                         duly adopted by the Board or upon the instructions of the Chief Executive Officer or
                                         based upon the advice of counsel for the Company shall be conclusively presumed to be
                                         done, or omitted to be done, by the Executive in good faith and in the best interests
                                         of the Company.

 

    7

     

    

 

		6.2	Termination
                                         by Executive. The Executive may voluntarily terminate employment under this Agreement
                                         for any reason by the service of written notice of such termination to the Company specifying
                                         an effective date of termination no sooner than thirty (30) days and no later than sixty
                                         (60) days after the date of such notice; provided, however, if less than thirty (30)
                                         days remain in the Term, the minimum notice required from the Executive under this Section
                                         6.2 shall be reduced from thirty (30) to seven (7) days. The Company reserves the right
                                         to end the employment relationship at any time after the date such notice is given to
                                         the Company and to pay the Executive through the Termination Date, which will not change
                                         the nature of the termination for purposes of this Agreement.

 

		6.3	Disability.
                                         If the Executive becomes “disabled” (as defined below), the Company may give
                                         the Executive written notice of its intention to terminate on the 30th day after receipt
                                         of the notice by the Executive. In the event the Executive is terminated due to Disability
                                         (a) all unvested awards granted to the Executive under the Equity Compensation Plans
                                         shall be immediately vested (provided performance-based restricted stock units shall
                                         only be payable subject to the attainment of the performance measures through the Termination
                                         Date (or the most recent practicable date) as provided under the terms of the applicable
                                         award agreement); and (b) any Company Non-Qualified Contributions shall be immediately
                                         vested. The Executive shall also receive a lump sum payment within thirty (30) days of
                                         the Termination Date of any PTO pay accrued but unused through the Termination Date.
                                         The right to the foregoing compensation due under clauses (a) and (b) above is subject
                                         to the timely execution, without revocation, by the Executive or the Executive’s
                                         legal representative of the Company’s waiver and release agreement substantially
                                         in the form attached hereto as “Exhibit B” which will operate as a release
                                         of all legally waivable claims against the Company. For purposes of this Section 6.3,
                                         the Executive is “disabled” if he or she is unable to perform the essential
                                         functions of the position (with or without reasonable accommodation) under this Agreement,
                                         which disability lasts for an uninterrupted period of at least 90 days or a total of
                                         at least 180 days out of any consecutive 360-day period, as a result of the Executive’s
                                         incapacity due to physical or mental illness (as determined by the opinion of an independent
                                         physician selected by the Company). In applying this Section 6.3, the Company will comply
                                         with any applicable legal requirements, including the Americans with Disabilities Act.

 

    8

     

    

 

		6.4	Death
                                         of Executive. If the Executive dies during the term of this Agreement, the Company
                                         may thereafter terminate this Agreement without compensation. In the event of the Executive’s
                                         death the Company will (a) immediately vest all unvested awards granted to the Executive
                                         under the Equity Compensation Plans (provided performance-based restricted stock units
                                         shall only be payable subject to the attainment of the performance measures through the
                                         Termination Date (or the most recent practicable date) as provided under the terms of
                                         the applicable award agreement); and (b) immediately vest any Company Non-Qualified Contributions.
                                         The Executive’s beneficiaries/estate shall also receive a lump sum payment within
                                         thirty (30) days of death of any PTO pay accrued but unused through the Termination
                                         Date. Amounts payable under this Section 6.4 shall be paid to the beneficiary designated
                                         on the Company’s universal beneficiary designation form in effect on the date of
                                         the Executive’s death. If the Executive fails to designate a beneficiary or if
                                         such designation is ineffective, in whole or in part, any payment that would otherwise
                                         have been paid under this Section 6.4 shall be paid to the Executive’s estate.
                                         The right to the foregoing compensation due under clauses (a) and (b) above is subject
                                         to the timely execution, without revocation, by the beneficiary, or as applicable, the
                                         administrator of the Executive’s estate of the Company’s waiver and release
                                         agreement substantially in the form attached hereto as “Exhibit B” which
                                         will operate as a release of all legally waivable claims against the Company.

 

		6.5	Effect
                                         of Termination. The termination of this Agreement, when accompanied by the termination
                                         of the Executive’s employment with the Company, will terminate all obligations
                                         of the Executive to render services on behalf of the Company from and after the Termination
                                         Date, provided that upon termination of this Agreement and termination of employment
                                         for any reason (other than by reason of the Executive’s death), the Executive shall
                                         comply with all post-employment requirements including this Section 6.5 and Sections
                                         7, 8, 9, 10, 11, 12 and 13, as well as the Company’s arbitration program. Except
                                         as otherwise provided in Section 6 of this Agreement and payment of any PTO pay accrued
                                         but unused through the Termination Date, no accrued bonus, severance pay or other form
                                         of compensation will be payable by the Company to the Executive by reason of the termination
                                         of this Agreement. All keys, entry cards, credit cards, files, records, financial information,
                                         Confidential Information (as defined below), research, results, test data, instructions,
                                         drawings, sketches, specifications, product data sheets, products, books, DVDs, disks,
                                         memory devices, business plans, marketing plans, documents, correspondence, furniture,
                                         furnishings, equipment, supplies and other items relating to the Company in the Executive’s
                                         possession will remain the property of the Company. Upon termination of employment, the
                                         Executive will have the right to retain and remove all personal property and effects
                                         which are owned by the Executive and located in the offices of the Company at a time
                                         determined by the Company. All such personal items will be removed from such offices
                                         no later than two (2) days after the Termination Date, and the Company is hereby authorized
                                         to discard any items remaining and to reassign the Executive’s office space after
                                         such date. Prior to the Termination Date, the Executive will render such services to
                                         the Company as might be reasonably required to provide for the orderly termination of
                                         the Executive’s employment. Notwithstanding the foregoing and without discharging
                                         any obligations to pay compensation to the Executive under this Agreement, after notice
                                         of the termination, the Company may request that the Executive not provide any other
                                         services to the Company and not enter the Company’s premises before or after the
                                         Termination Date. In the event that the Executive separates employment with the Company,
                                         the Executive hereby grants consent to notification by the Company to the Executive’s
                                         new employer about the Executive’s rights and obligations under this Agreement.
                                         Upon such termination of employment, the Executive further agrees to acknowledge compliance
                                         with this Agreement in a form reasonably provided by the Company.

 

    9

     

    

 

If
this Agreement is not terminated pursuant to any of the preceding provisions of Section 6 or extended by mutual written agreement
of the parties prior to the expiration of the Term, this Agreement and the Executive’s employment under this Agreement will
end and Company will have no further obligation to provide any further payments or benefits to the Executive under this Agreement
after the expiration of the Term other than any PTO pay accrued but unused through the expiration of the Term. Upon expiration
of this Agreement, the Executive will continue to be employed with Company on an at will basis until such employment is terminated
by either party, with or without any reason.

 

Unless
otherwise agreed to in writing by the Company and Executive prior to the termination of the Executive’s employment, any
termination of the Executive’s employment shall constitute (a) an automatic resignation of Executive as an officer of the
Company and each affiliate of the Company, (b) an automatic resignation of the Executive from the Board (if applicable) and from
the board of directors of any affiliate of the Company, and from the board of directors or similar governing body of any corporation,
limited liability entity or other entity in which the Company or any affiliate holds an equity interest and with respect to which
board or similar governing body the Executive serves as the Company’s or such affiliate’s designee or other representative
and (c) an automatic revocation of any power of attorney granted to the Executive for the benefit of the Company or any of its
affiliates.

 

		7.	Trade
                                         Secrets, Confidential Information and Inventions of the Company.

 

		7.1	Trade
                                         Secrets and Confidential Information. The Executive agrees that during the Executive’s
                                         employment hereunder, the Executive will have access to various trade secrets, confidential
                                         information and inventions of the Company as defined below.

 

		7.1.1	“Confidential
                                         Information” means all information and material which is proprietary to the Company,
                                         whether or not marked as “confidential” or “proprietary” and
                                         which is disclosed to or obtained from the Company by the Executive, which relates to
                                         the Company’s past, present or future research, development or business activities.
                                         Confidential Information includes all information or materials prepared by or for the
                                         Company and includes, without limitation, all of the following: designs, drawings, specifications,
                                         techniques, models, data, source code, object code, documentation, diagrams, flow charts,
                                         research, development, processes, systems, methods, machinery, procedures, “know-
                                         how”, new product or new technology information, formulas, patents, patent applications,
                                         product prototypes, product copies, cost of production, manufacturing, developing or
                                         marketing techniques and materials, cost of production, development or marketing time
                                         tables, customer lists, strategies related to customers, suppliers or personnel, contract
                                         forms, pricing policies and financial information, volumes of sales, and other information
                                         of similar nature, whether or not reduced to writing or other tangible form, and any
                                         other Trade Secrets, as defined by Section 7.1.3, or non-public business information.
                                         Confidential Information also will include any additional Company information with respect
                                         to which the Company took reasonable and apparent steps to preserve confidentiality.
                                         For purposes of this Agreement, the terms of this Agreement will be treated by the Executive
                                         as Confidential Information. Notwithstanding the foregoing, nothing in this Agreement,
                                         any other agreement between the Executive and the Company, or any Company policy shall
                                         be read to prevent the Executive from (a) sharing this Agreement or other information
                                         with the Executive’s attorney; (b) reporting possible violations of federal law
                                         or regulation to any governmental agency or entity including but not limited to the Department
                                         of Justice, the Securities and Exchange Commission, the Congress, and any Inspector General,
                                         or making other disclosures that are protected under the whistleblower provisions of
                                         federal law or regulation. The Executive will not need the prior authorization of the
                                         Company to make any such reports or disclosures and the Executive will not be required
                                         to notify the Company that he or she has made such reports or disclosures; (c) sharing
                                         information about this Agreement with the Executive’s spouse, accountant, attorney
                                         or financial advisor so long as the Executive ensures that such parties maintain the
                                         strict confidentiality of this Agreement; or (d) apprising any future or potential employer
                                         or other person or entity to which the Executive provides services of the Executive’s
                                         continuing obligations to the Company under this Agreement.

 

    10

     

    

 

		7.1.2	“Inventions”
                                         means all discoveries, concepts and ideas, whether patentable or not, including but not
                                         limited to, processes, methods, formulas, compositions, techniques, articles and machines,
                                         as well as improvements thereof or “know- how” related thereto, relating
                                         at the time of conception or reduction to practice to the business engaged in by the
                                         Company, or any actual or anticipated research or development by the Company.

 

		7.1.3	“Trade
                                         Secrets” means any scientific or technical data, information, design, process,
                                         procedure, formula or improvement that is commercially available to the Company and is
                                         not generally known in the industry.

 

This
Section 7.1 includes not only information belonging to the Company which existed before the date of this Agreement, but also information
developed by the Executive for the Company or its employees during the Executive’s employment and thereafter.

 

		7.2	Restriction
                                         on Use of Confidential Information. The Executive agrees that the Executive’s
                                         use of Trade Secrets and other Confidential Information is subject to the following restrictions
                                         during the term of the Agreement and for an indefinite period thereafter so long as the
                                         Trade Secrets and other Confidential Information have not become generally known to the
                                         public.

 

		7.3	Non-Disclosure.
                                         The Executive agrees that the Executive will not, directly or indirectly, use, make available,
                                         sell, disclose or otherwise communicate to any person, other than in the course of the
                                         Executive’s assigned duties and for the benefit of the Company, either during the
                                         period of the Executive’s employment or at any time thereafter, any Confidential
                                         Information or other confidential or proprietary information received from third parties
                                         subject to a duty of the Company’s and its subsidiaries’ and affiliates’
                                         part to maintain the confidentiality of such information, and to use such information
                                         only for certain limited purposes, in each case, which has been obtained by the Executive
                                         during the Executive’s employment by the Company (or any predecessor). The foregoing
                                         will not apply to information that (i) was known to the public prior to its disclosure
                                         to the Executive; (ii) becomes generally known to the public subsequent to disclosure
                                         to the Executive through no wrongful act of the Executive or any representative of the
                                         Executive; or (iii) the Executive is required to disclose by applicable law, regulation
                                         or legal process (provided that the Executive provides the Company with prior notice
                                         of the contemplated disclosure and cooperates with the Company at its expense in seeking
                                         a protective order or other appropriate protection of such information). Unless this
                                         Agreement is otherwise required to be disclosed under applicable law, rule or regulation,
                                         the terms and conditions of this Agreement will remain strictly confidential, and the
                                         Executive hereby agrees not to disclose the terms and conditions hereof to any person
                                         or entity, other than immediate family members, legal advisors or personal tax or financial
                                         advisors, or prospective future employers solely for the purpose of disclosing the limitations
                                         on the Executive’s conduct imposed by the provisions of this Agreement who, in
                                         each case, agree to keep such information confidential. The Executive is hereby notified
                                         in accordance with the Defend Trade Secrets Act of 2016 that the Executive will not be
                                         held criminally or civilly liable under any federal or state trade secret law for the
                                         disclosure of a trade secret that: (a) is made (i) in confidence to a federal, state,
                                         or local government official, either directly or indirectly, or to an attorney; and (ii)
                                         solely for the purpose of reporting or investigating a suspected violation of law; or
                                         (b) is made in a complaint or other document that is filed under seal in a lawsuit or
                                         other proceeding. The Executive is further notified that if he or she files a lawsuit
                                         for retaliation by the Company for reporting a suspected violation of law, the Executive
                                         may disclose the Company’s trade secrets to the Executive’s attorney and
                                         use the trade secret information in the court proceeding if he: (a) files any document
                                         containing the trade secret under seal; and (b) does not disclose the trade secret, except
                                         pursuant to court order. The provisions of this Section 7.3 will survive the expiration,
                                         suspension or termination of this Agreement for any reason.

 

    11

     

    

 

		7.4	Prohibition
                                         Against Unfair Competition. At any time after the termination of his or her employment
                                         with the Company for any reason, the Executive will not engage in competition with the
                                         Company while making use of the Trade Secrets of the Company.

 

		7.5	Patents
                                         and Inventions. The Executive agrees that any Inventions made, conceived or completed
                                         by the Executive during the term of the Executive’s service, solely or jointly
                                         with others, which are made with the Company’s equipment, supplies, facilities
                                         or Confidential Information, or which relate at the time of conception or reduction to
                                         purpose of the Invention to the business of the Company or the Company’s actual
                                         or demonstrably anticipated research and development, or which result from any work performed
                                         by the Executive for the Company, will be the sole and exclusive property of the Company,
                                         and all Trade Secrets, Confidential Information, copyrightable works, works of authorship,
                                         and all patents, registrations or applications related thereto, all other intellectual
                                         property or proprietary information and all similar or related information (whether or
                                         not patentable and copyrightable and whether or not reduced to tangible form or practice)
                                         which relate to the business, research and development, or existing or future products
                                         or services of the Company and/or its subsidiaries and which are conceived, developed
                                         or made by the Executive during the Executive’s employment with the Company (“Work
                                         Product”) will be deemed to be “work made for hire” (as defined in
                                         the Copyright Act, 17 U.S.C. §101 et seq., as amended) and owned exclusively by
                                         the Company. To the extent that any Work Product is not deemed to be a “work made
                                         for hire” under applicable law, and all right, title and interest in and to such
                                         Work Product have not automatically vested in the Company, the Executive hereby (a) irrevocably
                                         assigns, transfers and conveys, and will assign transfer and convey, to the fullest extent
                                         permitted by applicable law, all right, title and interest in and to the Work Product
                                         on a worldwide basis to the Company (or such other person or entity as the Company may
                                         designate), without further consideration, and (b) waives all moral rights in or to all
                                         Work Product, and to the extent such rights may not be waived, agrees not to assert such
                                         rights against the Company or its respective licensees, successors, or assigns. In order
                                         to permit the Company to claim rights to which it may be entitled, the Executive agrees
                                         to promptly disclose to the Company in confidence all Work Product which the Executive
                                         makes arising out of the Executive’s employment with the Company. The Executive
                                         will assist the Company in obtaining patents on all Work Product patentable by the Company
                                         in the United States and in all foreign countries, and will execute all documents and
                                         do all things necessary to obtain letters patent, to vest the Company with full and extensive
                                         title thereto, and to protect the same against infringement by others.

 

		8.	Non-Solicitation.
                                         The Executive agrees that during his or her employment hereunder, and for the one (1)
                                         year period immediately following termination of employment for any reason, the Executive
                                         shall not knowingly directly solicit goods, services or a combination of goods and services
                                         from any “Established Customers” of the Company. For purposes of this agreement,
                                         “Established Customer” means a customer, regardless of location, of the Company
                                         as of the date the Executive’s employment terminates who continues to be a customer
                                         or who the Company reasonably anticipates will continue to be a customer.

 

    12

     

    

 

		9.	Non-Solicitation
                                         of Employees and Independent Contractors. The Executive covenants that during the
                                         term of employment and for the one (1) year period immediately following the termination
                                         of employment for any reason, the Executive will not knowingly, directly or indirectly,
                                         induce or attempt to induce any executive, employee or independent contractor of the
                                         Company to terminate his/her employment relationship with the Company to go to work for
                                         any other company or third party.

 

		10.	Reasonableness.
                                         The Company and the Executive have attempted to specify a reasonable period of time and
                                         reasonable restrictions to which this Agreement shall apply. The Company and the Executive
                                         agree that if a court or administrative body should subsequently determine that the terms
                                         of this Agreement are greater than reasonably necessary to protect the Company’s
                                         interest, the Company agrees to waive those terms which are found by a court or administrative
                                         body to be greater than reasonably necessary to protect the Company’s interest
                                         and to request that the court or administrative body reform this Agreement specifying
                                         a reasonable period of time and such other reasonable restrictions as the court or administrative
                                         body deems necessary.

 

		11.	Equitable
                                         Relief. The Executive acknowledges that the services to be rendered by the Executive
                                         are of a special, unique, unusual, extraordinary, and intellectual character, which gives
                                         them a peculiar value, and the loss of which cannot reasonably or adequately be compensated
                                         in damages in an action at law; and that a breach by the Executive of any of the provisions
                                         contained in this Agreement will cause the Company irreparable injury and damage. The
                                         Executive further acknowledges that the Executive possesses unique skills, knowledge
                                         and ability and that any material breach of the provisions of this Agreement would be
                                         extremely detrimental to the Company. By reason thereof, the Executive agrees that the
                                         Company shall be entitled, in addition to any other remedies it may have under this Agreement
                                         or otherwise, to injunctive and other equitable relief from any court of competent jurisdiction
                                         to prevent or curtail any breach of this Agreement by him/her.

 

		12.	Continued
                                         Litigation Assistance. The Executive will cooperate with and assist the Company and
                                         its representatives and attorneys as requested, during and after the Term, with respect
                                         to any litigation, arbitration or other dispute resolutions by being available for interviews,
                                         depositions and/or testimony in regard to any matters in which the Executive is or has
                                         been involved or with respect to which the Executive has relevant information. The Company
                                         will reimburse the Executive for any reasonable business expenses the Executive may have
                                         incurred in connection with this obligation.

 

		13.	Arbitration.
                                         Except as provided in Section 11, any disputes, claims or controversies between the Company
                                         and the Executive including, but not limited to those arising out of or related to this
                                         Agreement or out of the parties’ employment relationship (together, “Employment
                                         Matter”), shall be settled by arbitration as provided herein. This agreement shall
                                         survive the termination or rescission of this Agreement. All arbitration shall be in
                                         accordance with Rules of the American Arbitration Association, including discovery, and
                                         shall be undertaken pursuant to the Federal Arbitration Act. Arbitration will be held
                                         in Oklahoma City, Oklahoma unless the parties mutually agree to another location.

 

The
decision of the arbitrator will be enforceable in any court of competent jurisdiction. The Executive and the Company agree that
either party shall be entitled to obtain injunctive or other equitable relief to enforce the provisions of this Agreement in a
court of competent jurisdiction. The parties further agree that this arbitration provision is not only applicable to the Company
but its affiliates, officers, directors, employees and related parties. The Executive agrees that the Executive shall have no
right or authority for any dispute to be brought, heard or arbitrated as a class or collective action, or in a representative
or a private attorney general capacity on behalf of a class of persons or the general public. No class, collective or representative
actions are thus allowed to be arbitrated. The Executive agrees that he or she must pursue any claims that he or she may have
solely on an individual basis through arbitration.

 

    13

     

    

 

		14.	Miscellaneous.
                                         The parties further agree as follows:

 

		14.1	Time.
                                         Time is of the essence of each provision of this Agreement.

 

		14.2	Notices.
                                         Any notice, payment, demand or communication required or permitted to be given by any
                                         provision of this Agreement will be in writing and will be deemed to have been given
                                         when delivered personally or by express mail to the party designated to receive such
                                         notice, or on the date following the day sent by overnight courier, or on the third business
                                         day after the same is sent by certified mail, postage and charges prepaid, directed to
                                         the following address or to such other or additional addresses as any party might designate
                                         by written notice to the other party:

 

	 	To the Company: 	Gulfport
                                         Energy Corporation
	 	 	3001
                                         Quail Springs Parkway

Oklahoma
City, Oklahoma 73134

Attention:
Board of Directors

	 	 	 
	 	To
                                         the Executive:	The
                   most recent home address reflected in the records of the Company.

  

		14.3	Assignment.
                                         Neither this Agreement nor any of the parties’ rights or obligations hereunder
                                         can be transferred or assigned without the prior written consent of the other parties
                                         to this Agreement; provided, however, the Company may assign this Agreement to any wholly
                                         owned affiliate or subsidiary of the Company without the Executive’s consent as
                                         well as to any purchaser of the Company.

 

In
the opinion of Independent Advisors, constitutes reasonable compensation for services actually rendered, within the meaning of
Section 280G(b)(4)(B) of the Code, in excess of the “base amount” (as defined in Section 280G(b)(3) of the Code) allocable
to such reasonable compensation, and (iii) the value of any non-cash benefit or any deferred payment or benefit included in the
Total Payments shall be determined by the Independent Advisors in accordance with the principles of Sections 280G(d)(3) and (4)
of the Code. The costs of obtaining such determination shall be borne by the Company.

 

    14

     

    

 

		14.4	Construction.
                                         If any provision of this Agreement or the application thereof to any person or circumstances
                                         is determined, to any extent, to be invalid or unenforceable, the remainder of this Agreement,
                                         or the application of such provision to persons or circumstances other than those as
                                         to which the same is held invalid or unenforceable, will not be affected thereby, and
                                         each term and provision of this Agreement will be valid and enforceable to the fullest
                                         extent permitted by law. This Agreement is intended to be interpreted, construed and
                                         enforced in accordance with the laws of the State of Oklahoma.

 

		14.5	Entire
                                         Agreement. This Agreement, any documents executed in connection with this Agreement,
                                         any documents specifically referred to in this Agreement constitute the entire agreement
                                         between the parties hereto with respect to the subject matter herein contained, and no
                                         modification hereof will be effective unless made by a supplemental written agreement
                                         executed by all of the parties hereto.

 

		14.6	Binding
                                         Effect. This Agreement will be binding on the parties and their respective successors,
                                         legal representatives and permitted assigns. In the event of a merger, consolidation,
                                         combination, dissolution or liquidation of the Company, the performance of this Agreement
                                         will be assumed by any entity which succeeds to or is transferred the business of the
                                         Company as a result thereof, and the Executive waives the consent requirement of Section
                                         14.3 to effect such assumption.

 

		14.7	Supersession.
                                         On execution of this Agreement by the Company and the Executive, the relationship between
                                         the Company and the Executive will be bound by the terms of this Agreement, any documents
                                         executed in connection with this Agreement, any documents specifically referred to in
                                         this Agreement as well as any other agreements executed in connection with the Executive’s
                                         employment with the Company. In the event of a conflict between any employment policy
                                         of the Company and this Agreement, this Agreement will control in all respects.

 

		14.8	Third-Party
                                         Beneficiary. The Company’s affiliated entities and partnerships are beneficiaries
                                         of all terms and provisions of this Agreement and entitled to all rights hereunder.

 

		14.9	Section
                                         409A. This Agreement is intended to be exempt from Section 409A of the Internal Revenue
                                         Code of 1986, as amended (the “Code”), and related U.S. Treasury regulations
                                         or official pronouncements (“Section 409A”) and any ambiguous provision will
                                         be construed in a manner that is compliant with such exemption; provided, however, if
                                         and to the extent that any compensation payable pursuant to this Agreement is determined
                                         to be subject to Section 409A, this Agreement will be construed in a manner that will
                                         comply with Section 409A. Notwithstanding any provision to the contrary in this Agreement,
                                         if the Executive is deemed on his or her Termination Date to be a “specified employee”
                                         within the meaning of that term under Section 409A, then any payments and benefits under
                                         this Agreement that are subject to Section 409A and paid by reason of a termination of
                                         employment shall be made or provided on the later of (a) the payment date set forth in
                                         this Agreement or (b) the date that is the earliest of (i) the expiration of the six-month
                                         period measured from the date of the Executive’s termination of employment or (ii)
                                         the date of the Executive’s death (the “Delay Period”). Payments and
                                         benefits subject to the Delay Period shall be paid or provided to the Executive without
                                         interest for such delay. Termination of employment as used throughout this Agreement
                                         shall refer to a separation from service within the meaning of Section 409A. To the extent
                                         required to comply with Section 409A, references to a “resignation,” “termination,”
                                         “termination of employment” or like terms throughout this Agreement shall
                                         be interpreted consistent with the meaning of “separation from service” as
                                         defined in Section 409A.

 

    15

     

    

 

		14.10	Clawback.
                                         Notwithstanding anything in this Agreement or any other agreement between the Company
                                         and/or its related entities and the Executive to the contrary, the Executive acknowledges
                                         that the Dodd-Frank Wall Street Reform and Consumer Protection Act (“Act”)
                                         may have the effect of requiring certain executives of the Company and/or its related
                                         entities to repay the Company, and for the Company to recoup from such executives, certain
                                         amounts of incentive-based compensation. If, and only to the extent, the Act, any rules
                                         and regulations promulgated by thereunder by the Securities and Exchange Commission or
                                         any similar federal or state law requires the Company to recoup incentive-based compensation
                                         that the Company has paid or granted to the Executive, the Executive hereby agrees, even
                                         if the Executive has terminated his or her employment with the Company, to promptly repay
                                         such incentive compensation to the Company upon its written request. In addition, the
                                         Executive agrees to be subject to any other compensation clawback arrangement adopted
                                         by the Board (whether before or after the Effective Date) which is applicable to all
                                         executive officers of the Company. This Section 14.10 shall survive the termination of
                                         this Agreement.

 

		14.11	Maximum
                                         Payments by the Company.

 

		(a)	It
                                         is the objective of this Agreement to maximize the Executive’s Net After-Tax Benefit
                                         (as defined herein) if payments or benefits provided under this Agreement are subject
                                         to excise tax under Section 4999 of the Code. Notwithstanding any other provisions of
                                         this Agreement, in the event that any payment or benefit by the Company or otherwise
                                         to or for the benefit of the Executive, whether paid or payable or distributed or distributable
                                         pursuant to the terms of this Agreement or otherwise, including, by example and not by
                                         way of limitation, acceleration by the Company or otherwise of the date of vesting or
                                         payment or rate of payment under any plan, program, arrangement or agreement of the Company
                                         (all such payments and benefits, including the payments and benefits under Section 6
                                         hereof, being hereinafter referred to as the “Total Payments”), would be
                                         subject (in whole or in part) to the excise tax imposed by Section 4999 of the Code (the
                                         “Excise Tax”), then the cash severance payments shall first be reduced, and
                                         the non-cash severance payments shall thereafter be reduced, to the extent necessary
                                         so that no portion of the Total Payments shall be subject to the Excise Tax, but only
                                         if (i) the net amount of such Total Payments, as so reduced (and after subtracting the
                                         net amount of federal, state and local income taxes on such reduced Total Payments and
                                         after taking into account the phase out of itemized deductions and personal exemptions
                                         attributable to such reduced Total Payments), is greater than or equal to (ii) the net
                                         amount of such Total Payments without such reduction (but after subtracting the net amount
                                         of federal, state and local income taxes on such Total Payments and the amount of Excise
                                         Tax to which the Executive would be subject in respect of such unreduced Total Payments
                                         and after taking into account the phase out of itemized deductions and personal exemptions
                                         attributable to such unreduced Total Payments).

 

		(b)	The
                                         Total Payments shall be reduced by the Company in the following order: (i) reduction
                                         of any cash severance payments otherwise payable to the Executive that are exempt from
                                         Section 409A of the Code, (ii) reduction of any other cash payments or benefits otherwise
                                         payable to the Executive that are exempt from Section 409A of the Code, but excluding
                                         any payments attributable to the acceleration of vesting or payments with respect to
                                         any equity award with respect to the Company’s common stock that is exempt from
                                         Section 409A of the Code, (iii) reduction of any other payments or benefits otherwise
                                         payable to the Executive on a pro-rata basis or such other manner that complies with
                                         Section 409A of the Code, but excluding any payments attributable to the acceleration
                                         of vesting and payments with respect to any equity award with respect to the Company’s
                                         common stock that are exempt from Section 409A of the Code, and (iv) reduction of any
                                         payments attributable to the acceleration of vesting or payments with respect to any
                                         other equity award with respect to the Company’s common stock that are exempt from
                                         Section 409A of the Code.

 

		(c)	For
                                         purposes of determining whether and the extent to which the Total Payments will be subject
                                         to the Excise Tax, (i) no portion of the Total Payments the receipt or enjoyment of which
                                         the Executive shall have waived at such time and in such manner as not to constitute
                                         a “payment” within the meaning of Section 280G(b) of the Code shall be taken
                                         into account, (ii) no portion of the Total Payments shall be taken into account which,
                                         in the written opinion of independent auditors of nationally recognized standing (“Independent
                                         Advisors”) selected by the Company, does not constitute a “parachute payment”
                                         within the meaning of Section 280G(b)(2) of the Code (including by reason of Section
                                         280G(b)(4)(A) of the Code) and, in calculating the Excise Tax, no portion of such Total
                                         Payments shall be taken into account which,

 

[Signature
Page Follows]

 

    16

     

    

 

IN
WITNESS WHEREOF, the undersigned have executed this Agreement effective the date first above written.

 

	 	GULFPORT ENERGY CORPORATION, 

a Delaware corporation
	 	 
	 	By:	 
	 	Name:  	David M. Wood
	 	Title:  	President and Chief Executive Officer
	 	 	 
	 	By:	 
	 	 	Michael Sluiter, Individually 
	 	 	(the “Executive”)

 

     

     

    

 

Exhibit
A

 

For
purposes of this Agreement, “Change in Control” means:

 

(a) The
direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a
series of related transactions, of all or substantially all of the assets of the Company to any Person (as that term is used in
Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”));

 

(b) The
individuals who constitute the Board (the “Incumbent Directors”) as of the beginning of the period cease for any reason
to constitute at least a majority of the Board. Any individual becoming a director whose election or nomination for election to
the Board was approved by a vote of at least two- thirds of the Incumbent Directors then on the Board (either by a specific vote
or by approval of the proxy statement of the Company in which that person is named as a nominee for Director without objection
to the nomination) will be an Incumbent Director. No individual initially elected or nominated as a Director of the Company as
a result of an actual or threatened election contest with respect to Directors or as a result of any other actual or threatened
solicitation of proxies by or on behalf of any person other than the Board will be an Incumbent Director;

 

(c) The
adoption of a plan relating to the liquidation or dissolution of the Company; or

 

(d) The
consummation of any transaction (including, without limitation, any merger, consolidation or exchange) resulting in any Person
or Group (as such terms are used for purposes of Sections 13(d) and 14(d) of the Exchange Act) becoming the Beneficial Owner (as
defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of more than 30% of the combined voting power (which voting
power shall be calculated by assuming the conversion of all equity securities convertible (immediately or at some future time)
into shares entitled to vote, but not assuming the exercise of any warrant or right to subscribe to or purchase those shares)
of the continuing or surviving entity’s securities outstanding immediately after such transaction, or the consummation of
any transaction in which more than 50% of the combined voting power of the surviving entity immediately after such transaction
is owned, directly or indirectly, by persons who were not stockholders of the Company immediately prior to such merger, consolidation,
reorganization or sale of stock; provided, however, that in making the determination of ownership by the stockholders of the Company,
immediately after the reorganization, equity securities which persons own immediately before the reorganization as stockholders
of another party to the transaction shall be disregarded.

 

The
foregoing notwithstanding, a transaction will not constitute a Change in Control if (x) its sole purpose is to change the state
of the Company’s incorporation or to create a holding company that will be owned in substantially the same proportions by
the Persons who held the Company’s securities immediately before the transaction; (y) it constitutes an initial public offering
or a secondary public offering that results in any security of the Company being listed (or approved for listing) on any securities
exchange or designated (or approved for designation) as a security on an interdealer quotation system; or (z) solely because 50%
or more of the total voting power of the Company’s then outstanding securities is acquired by (1) a trustee or other fiduciary
holding securities under one or more employee benefit plans of the Company or any parent corporation or subsidiary corporation
of the Company (as defined in Code Sections 424(e) and (f)), or (2) any company that, immediately before the acquisition, is owned
directly or indirectly by the stockholders of the Company in substantially the same proportion as their ownership of stock in
the Company immediately before the acquisition.

 

    A-1

     

    

 

Exhibit
B

 

Form
of Waiver and Release

 

(attached)

 

 

 

 

 

 

 

 

 

 

 

 

    B-1

     

    

 

FORM
OF WAIVER AND RELEASE

 

[The
language in this Waiver and Release may change based on legal developments and evolving best practices; this form is provided
as an example of what will be included in the final Waiver and Release document.]

 

In
consideration of, and as a condition precedent to, receiving the termination compensation described in that certain Employment
Agreement (the “Agreement”) effective as of November 13, 2020, by and between Gulfport Energy Corporation,
a Delaware corporation (the “Company”), and [________________], an individual residing in the State of [______] (“Employee”),
which was offered to Employee in exchange for a general waiver and release of claims (this “Waiver and Release”).
Employee having acknowledged the above-stated consideration as full compensation for and on account of any and all injuries and
damages which Employee has sustained or claimed, or may be entitled to claim, Employee, for himself, and his heirs, executors,
administrators, successors and assigns, does hereby release, forever discharge and promise not to sue the Company, its parents,
subsidiaries, affiliates, successors and assigns, and their past and present officers, directors, partners, employees, members,
managers, shareholders, agents, attorneys, accountants, insurers, heirs, administrators, executors, as well as all employee benefit
plans maintained by any of the foregoing entities or individuals, and all fiduciaries and administrators of such plans, in their
personal and representative capacities (collectively the “Released Parties”) from any and all claims, liabilities,
costs, expenses, judgments, attorney fees, actions, known and unknown, of every kind and nature whatsoever in law or equity, which
Employee had, now has, or may have against the Released Parties, including but not limited to any claims relating in any way to
Employee’s employment with the Company or termination thereof prior to and including the date of execution of this Waiver
and Release, and including but not limited to, all claims for contract damages, tort damages, special, general, direct, punitive
and consequential damages, compensatory damages, loss of profits, attorney fees and any and all other damages of any kind or nature;
all contracts, oral or written, between Employee and any of the Released Parties; any business enterprise or proposed enterprise
contemplated by any of the Released Parties, as well as anything done or not done prior to and including the date of execution
of this Waiver and Release.

 

Employee
understands and agrees that this Waiver and Release and covenant not to sue shall apply to any and all claims or liabilities arising
out of or relating to Employee’s employment with the Company and the termination of such employment, including, but not
limited to: claims of discrimination based on age, race, color, sex (including sexual harassment), religion, national origin,
marital status, parental status, veteran status, union activities, disability or any other grounds under applicable federal, state
or local law prior to and including the date of execution of this Waiver and Release, including, but not limited to, claims arising
under the Age Discrimination in Employment Act of 1967, the Americans with Disabilities Act, the Family and Medical Leave Act,
Title VII of the Civil Rights Act, the Civil Rights Act of 1991, 42 U.S.C. § 1981, the Genetic Information Non-Discrimination
Act of 2008, the Employee Retirement Income Security Act of 1974, the Consolidated Omnibus Budget Reconciliation Act of 1985,
the Rehabilitation Act of 1973, the Equal Pay Act of 1963 (EPA), all as amended, as well as any claims prior to and including
the date of execution of this Waiver and Release, regarding wages; benefits; vacation; sick leave; business expense reimbursements;
wrongful termination; breach of the covenant of good faith and fair dealing; intentional or negligent infliction of emotional
distress; retaliation; outrage; defamation; invasion of privacy; breach of contract; fraud or negligent misrepresentation; harassment;
breach of duty; negligence; discrimination; claims under any employment, contract or tort laws; claims arising under any other
federal law, state law, municipal law, local law, or common law; any claims arising out of any employment contract, policy or
procedure; and any other claims related to or arising out of his employment or the separation of his employment with the Company
prior to and including the date of execution of this Waiver and Release.

 

    B-2

     

    

 

In
addition, Employee agrees not to cause or encourage any legal proceeding to be maintained or instituted against any of the Released
Parties, save and except proceedings to enforce the terms of the Agreement or claims of Employee not released by and in this Waiver
and Release.

 

This
Waiver and Release does not apply to (i) claims for indemnification pursuant to the Company’s governing documents or any
indemnification agreement, (ii) vested benefits under any retirement plan of the Company, (iii) any claims for unemployment compensation
or (iv) any other claims or rights which, by law, cannot be waived, including the right to file an administrative charge or participate
in an administrative investigation or proceeding; provided, however that Employee disclaims and waives any right to share or participate
in any monetary award from the Company resulting from the prosecution of such charge or investigation or proceeding. Notwithstanding
the foregoing or any other provision in this Waiver and Release or the Agreement to the contrary, the Company and Employee further
agree that nothing in this Waiver and Release or the Agreement (i) limits Employee’s ability to file a charge or complaint
with the EEOC, the NLRB, OSHA, the SEC or any other federal, state or local governmental agency or commission (each a “Government
Agency” and collectively “Government Agencies”); (ii) limits Employee’s ability to communicate with any
Government Agencies or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency,
including providing documents or other information and reporting possible violations of law or regulation or other disclosures
protected under the whistleblower provisions of applicable law or regulation, without notice to the Company; or (iii) limits Employee’s
right to receive an award for information provided to any Government Agencies.

 

Employee
expressly acknowledges that he is voluntarily, irrevocably and unconditionally releasing and forever discharging the Company and
the other Released Parties from all rights or claims he has or may have against the Released Parties including, but not limited
to, without limitation, all charges, claims of money, demands, rights, and causes of action arising under the Age Discrimination
in Employment Act of 1967, as amended (“ADEA”), up to and including the date Employee signs this Waiver and Release
including, but not limited to, all claims of age discrimination in employment and all claims of retaliation in violation of ADEA.
Employee further acknowledges that the consideration given for this waiver of claims under the ADEA is in addition to anything
of value to which he was already entitled in the absence of this waiver. Employee further acknowledges: (a) that he has been informed
by this writing that he should consult with an attorney prior to executing this Waiver and Release; (b) that he has carefully
read and fully understands all of the provisions of this Waiver and Release; (c) he is, through this Waiver and Release, releasing
the Company and the other Released Parties from any and all claims he may have against any of them; (d) he understands and agrees
that this Waiver and Release does not apply to any claims that may arise under the ADEA after the date he executes this Waiver
and Release; (e) he has at least twenty-one (21) days within which to consider this Waiver and Release; and (f) he has seven (7)
days following his execution of this Waiver and Release to revoke the Waiver and Release; and (g) this Waiver and Release shall
not be effective until the revocation period has expired and Employee has signed and has not revoked the Waiver and Release.

 

    B-3

     

    

 

Employee
acknowledges and agrees that: (a) he has had reasonable and sufficient time to read and review this Waiver and Release and that
he has, in fact, read and reviewed this Waiver and Release; (b) that he has the right to consult with legal counsel regarding
this Waiver and Release and is encouraged to consult with legal counsel with regard to this Waiver and Release; (c) that he has
had (or has had the opportunity to take) twenty-one (21) calendar days to discuss the Waiver and Release with a lawyer of his
choice before signing it and, if he signs before the end of that period, he does so of his own free will and with the full knowledge
that he could have taken the full period; (d) that he is entering into this Waiver and Release freely and voluntarily and not
as a result of any coercion, duress or undue influence; (e) that he is not relying upon any oral representations made to him regarding
the subject matter of this Waiver and Release; (f) that by this Waiver and Release he is receiving consideration in addition to
that which he was already entitled; and (g) that he has received all information he requires from the Company in order to make
a knowing and voluntary release and waiver of all claims against the Company and the other Released Parties.

 

Employee
acknowledges and agrees that he has seven (7) days after the date he signs this Waiver and Release in which to rescind or revoke
this Waiver and Release by providing notice in writing to the Company. Employee further understands that the Waiver and Release
will have no force and effect until the end of that seventh (7th) day. If Employee revokes the Waiver and Release, the Company
will not be obligated to pay or provide Employee with the benefits described in this Waiver and Release, and this Waiver and Release
shall be deemed null and void.

 

AGREED
TO AND ACCEPTED this ______ day of ______________, 20__.

  

	 	 	 
	 	 	[Name]

 

 

B-4Exhibit 10.1

 

	AWARD/CONTRACT	1.      THIS CONTRACT IS A RATED ORDER

UNDER DPAS (15 CFR 700)	RATING	PAGE OF PAGES
	1	30
	
        2.     
        CONTRACT (Pros. Inst. Ident.) NO

        W911SR2030004
	
        3.     
        EFFECTIVE DATE

        01 Jul 2020
	
        4.     
        REQUISITION/PURCHASE REQUEST/PROJECT NO.

        0011506626-0001

	5.      ISSUED BY	CODE	W911SR	6.      ADMINISTERED BY (If other than Item 5)	CODE	S4402A
	
        US ARMY RDECOM CONTRACTING CMD

        APG, EDGEWOOD CONTRACTING DIVISION

        E4455 LEITZAN ROAD

        ABERDEEN PROVING GROUND MD 21010-5401

         
	
        DCMA DALLAS – S4402A

        600 NORTH PEARL STREET

        SUITE 1630

        DALLAS TX 75201-2843

	
        7.     
        NAME AND ADDRESS OF CONTRACTOR (No., street, city, county, state and zip code)

        RETRACTABLE TECHNOLOGIES, INC.

        511 LOBO LN

        LITTLE ELM TX 75068-5295

         

         
	
        8.     
        DELIVERY

        [ ] FOB ORIGIN       [ ] OTHER (See
        below)

	
        9. DISCOUNT FOR PROMPT PAYMENT

        Net 30 Days

	
        10. SUBMIT INVOICES

        (4 copies unless otherwise specified)

        TO THE ADDRESS
	ITEM
	CODE         1BFK3	FACILITY CODE	SHOWN IN:	 
	11.  SHIP TO/MARK FOR:	CODE	W56XNH	12.   PAYMENT WILL BE MADE BY	CODE	HQ0339
	
        BIOMEDICAL ADVANCED RESEARCH DEVELOPMENT

        [JOSEPH
        FIGLIO]

        ROOM 23E07

        O’NEILL HOUSE OFFICE BUILDING

        WASHINGTON DC 20515

         
	
        DFAS-COLUMBUS CENTER

        DFAS-COM/EST ENTITLEMENT OPERATIONS

        P.O. BOX 182381

        COLUMBUS OH 43218-2381

         

	
        13.  
        AUTHORITY FOR USING OTHER THAN FULL AND OPEN COMPETITION:

        [ ] 10 U.S.C. 2304(c)( ) [ ] 41 U.S.C.
        253(c)( )
	
        14.  
        ACCOUNTING AND APPROPRIATION DATA

        See Schedule

	15A.  ITEM NO.	15B.  SUPPLIES/SERVICES	15C.  QUANTITY	15D.  UNIT	15E.  UNIT PRICE	15F.  AMOUNT
	
         

         

         

         

         
	
         

         

        SEE SCHEDULE
	 	 	 	 
	15G.	TOTAL AMOUNT OF CONTRACT	$53,664,286.00
	16.  TABLE OF CONTENTS
	(X)	SEC.	DESCRIPTION	PAGE(S)	(X)	SEC.	DESCRIPTION	PAGE(S)
	PART I – THE SCHEDULE	PART II – CONTRACT CLAUSES
	X	A	SOLICITATION/CONTRACT FORM	1	X	1	CONTRACT CLAUSES	15-30
	X	B	SUPPLIES OR SERVICES AND PRICES/C0STS	2	PART III – LIST OF DOCUMENTS, EXHIBITS AND OTHER ATTACH
	 	C	DESCRIPTION/SPECS/WORK STATEMENT	 	 	J	LIST OF ATTACHMENTS	 
	 	D	PACKAGING AND MARKING	 	PART IV – REPRESENTATIONS AND INSTRUCTIONS
	X	E	INSPECTION AND ACCEPTANCE	3	 	K	REPRESENTATIONS, CERTIFICATIONS AND	 
	X	F	DELIVERIES OR PERFORMANCE	4-5	 	 	OTHER STATEMENTS OF OFFERORS	 
	X	G	CONTRACT ADMINISTRATION DATA	6	 	L	INSTRS., CONDS., AND NOTICES TO OFFERORS	 
	X	H	SPECIAL CONTRACT REQUIREMENTS	7-14	 	M	EVALUATION FACTORS FOR AWARD	 
	CONTRACTING OFFICER WILL COMPLETE ITEM 17 (SEALED-BID OR NEGOTIATED PROCUREMENT) OR 18 (SEALED-BID PROCUREMENT) AS APPLICABLE
	
        17 [ ] CONTRACTOR’S
        NEGOTIATED AGREEMENT. Contractor is required to sign this document and return ______ copies
        to issuing office. Contractor agrees to furnish and deliver all items or perform all the
        services set forth or otherwise identified above and on any continuation sheets for the consideration stated herein. The rights
        and obligations of the parties to this contract shall be subject to and governed by the following documents: (a) this award contract,
        (b) the solicitation, if any, and (c) such provisions, representations, certifications, and specifications as are attached or incorporated
        by reference herein.

        (Attachments are listed herein.)
	
        18. [ ] SEALED-BID
        AWARD (Contractor is not required to sign this document.)

         

        Your bid on Solicitation Number ____________________

         

        Including the additions or changes made by
        you which additions or changes are set forth in full above, is hereby accepted as to the terms listed above and on any continuation
        sheets. This award consummates the contract which consists of the following documents: (a) the Government’s solicitation
        and our bid, and (b) this award contract. No further contractual document is necessary. (Block 18 should be checked only when awarding
        a sealed-bid contract.)

	
        19A. NAME AND TITLE OF SIGNER (Type or print)

         

        [THOMAS
        J. SHAW]
	
        20A. NAME OF CONTRACTING OFFICER[

        [[John
        Conlin, Agreements Officer]

        TEL: [508-206-2064]
        EMAIL: [john.conlin3.civ@mail.mil]

	
        19B. NAME OF CONTRACTOR

         

         

        By:_[/s/Thomas
        J. Shaw]____________________

        (Signature of person authorized to sign)
	
        19C. DATE SIGNED

         

         

        7/1/2020
	
        20B. UNITED STATES OF AMERICA

         

         

        By: [/s/
        JC]__________________________________

        (Signature of Contracting Officer)
	
        20C. DATE SIGNED

         

        1 July 2020

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

    	 	 	 

     

    

 

Section B – Supplies or Services
and Prices

 

 

	ITEM NO.	SUPPLIES/SERVICES	QUANTITY	UNIT	UNIT PRICE	AMOUNT	 
	0001	 	 	[Job]	 	$53,664,286.00 NTE
	 	TECHNOLOGY INVESTMENT AGREEMENT	 	 
	 	COST	 	 
	 	 	 	 
	 	Technology Investment Agreement (TIA) for Expanding Domestic Production of Needles & Syringes IAW vendor project plan dated [18 JUN 20.]	 	 
	 	 	 	 
	 	FOB:  Destination	 	 
	 	PURCHASE REQUEST NUMBER:  [0011506626-0001]	 	 
	 	PSC CD:  [6515]	 	 
	 	 	 	 	ESTIMATED COST	$53,664,286.00	 
	 	ACRN AA	 	 	 	[$53,664,286.00]	 
	 	CIN:  [GFEBS001150662600001]	 	 	 	 
	 	 	 	 
	 	 	 	 	 	 	 	 

 

    	 	 	 

     

    

 

Section E – Inspection and Acceptance

 

 

INSPECTION AND ACCEPTANCE OF TERMS

 

Supplies/services will be inspected/accepted
at:

 

	CLIN	INSPECT AT	INSPECT BY	ACCEPT AT	ACCEPT BY
	0001	Destination	Government	Destination	Government

 

    	 	 	 

     

    

 

Section F – Deliveries or Performance

 

 

F.1  Supply
Chain Resiliency Plan

 

F.2  The
contractor shall develop and submit at the time of agreement award, a comprehensive Supply Chain Resiliency Program that provides
identification and reporting of critical components associated with the secure supply of drug substance, drug product, and work-in-process
through to finished goods.

		a)	A critical component is defined as any material that is essential to the product or the manufacturing
process associated with that product. Included in the definition are consumables and disposables associated with manufacturing.
NOT included in the definition are facility and capital equipment.

 

F.3  Consideration
of critical components includes the evaluation and potential impact of raw materials, excipients, active ingredients, substances,
pieces, parts, software, firmware, labeling, assembly, testing, analytical and environmental componentry, reagents, or utility
materials which are used in the manufacturing of a drug, cell banks, seed stocks, devices and key processing components and equipment.
A clear example of a critical component is one where a sole supplier is utilized.

 

F.4  The
contractor shall identify key equipment suppliers, their locations, local resources, and the associated control processes at the
time of award. This document shall address planning and scheduling for active pharmaceutical ingredients, upstream, downstream,
component assembly, finished drug product and delivery events as necessary for the delivery of product.

		a)	Communication for these requirements shall be updated as part of an annual
review, or as necessary, as part of regular contractual communications.

		b)	For upstream and downstream processing, both single-use and re-usable in-place
processing equipment, and manufacturing disposables also shall be addressed. For finished goods, the inspection, labeling, packaging,
and associated machinery shall be addressed taking into account capacity capabilities.

		c)	The focus on the aspects of resiliency shall be on critical components and
aspects of complying with the contractual delivery schedule. Delivery methods shall be addressed, inclusive of items that are foreign-sourced,
both high and low volume, which would significantly affect throughput and adherence to the contractually agreed deliveries.

 

F.5  The
contractor shall articulate in the plan, the methodology for inventory control, production planning, scheduling processes and ordering
mechanisms, as part of those agreed deliveries.

		a)	Production rates and lead times shall be understood and communicated to
the HHS/ASPR/BARDA Agreements Officer (AO) or the Agreements Officer’s Representative (AOR) as necessary.

		b)	Production throughput critical constraints should be well understood by
activity and by design, and communicated to contractual personnel. As necessary, communication should focus on identification,
exploitation, elevation, and secondary constraints of throughput, as appropriate.

 

F.6  Reports
for critical items should include the following information:

		a)	Critical Material

		b)	Vendor

		c)	Supplier, Manufacturing / Distribution Location

		d)	Supplier Lead Time

		e)	Shelf Life

		f)	Transportation / Shipping restrictions

 

F.7  The
AO and AOR reserve the right to request un-redacted copies of technical documents, during the period of performance, for distribution
within the Government Documents shall be provided within ten (10) days after AO issues the request. The Contractor may arrange
for additional time if deemed necessary, and agreed to by the AO.

 

    	 	 	 

     

    

 

DELIVERY INFORMATION

 

 

	CLIN	DELIVERY DATE	QUANTITY	SHIP TO ADDRESS	
        DODAAC/

        CAGE

	0001	
        POP 01-JUL-2020 TO

        30-JUN-2030
	[N/A]	
        [BIOMEDICAL
        ADVANCED RESEARCH

        DEVELOPMENT

        JOSEPH
        FIGLIO

        ROOM
        23E07

        O’NEILL
        HOUSE OFFICE BUILDING

        WASHINGTON
        DC 20515]

        FOB: Destination
	W56XNH
	 	 	 	 	 	 

 

    	 	 	 

     

    

 

Section G – Contract Administration
Data

 

 

ACCOUNTING AND APPROPRIATION
DATA

 

 

AA: [0212020202120400000664643255S.0074658.5.16100.9000021001]

COST CODE: [A5XAH]

AMOUNT: $53,664,286.00

 

 

	ACRN	CLIN/SIN	CIN	AMOUNT
	 	 	 	 
	AA	0001	[GFEBS001150662600001]	$53,664,286.00

 

    	 	 	 

     

    

 

Section H – Special Contract
Requirements

 

 

H.1         Key
Personnel

 

H.1.1       Pursuant
to HHSAR 352.237-75 (Dec. 2015), Key Personnel, any key personnel specified in this agreement are considered to be essential to
work performance. At least thirty (30) calendar days prior to the Contractor voluntarily diverting any of the specified individuals
to other programs or agreements the Contractor shall notify the Agreements Office and shall submit a justification for the diversion
or replacement and a request to replace the individual. The request must identify the proposed replacement and provide an explanation
of how the replacement's skills, experience, and credentials meet or exceed the requirements of the agreement (including, when
applicable, Human Subjects Testing requirements). If the employee of the Contractor is terminated for cause or separates from the
Contractor voluntarily with less than thirty (30) calendar-day notice, the Contractor shall provide the maximum notice practicable
under the circumstances. The Contractor shall not divert, replace. or announce any such change to key personnel without the written
consent of the Agreements Officer. The agreement will be modified to add or delete key personnel as necessary to reflect the agreement
of the parties. The following individuals are determined to be key personnel.

 

H.1.2       Substitution
of Key Personnel

 

H.1.2.1   The
Contractor agrees to assign to the agreement those persons whose resumes/CVs were submitted with the proposal who are necessary
to fill the requirements of the agreement. No substitutions shall be made except in accordance with this clause.

 

H.1.2.2   All
requests for substitution must provide a detailed explanation of the circumstance necessitating the proposed substitution, a complete
resume for the proposed substitute and any other information requested by the Agreements Officer to approve or disapprove the proposed
substitution. All proposed substitutes must have qualifications that are equal to or higher than the qualifications of the person
to be replaced. The Agreements Officer or authorized representative will evaluate such requests and promptly notify the Contractor
of his approval or disapproval thereof.

 

H.1.2.3   The
Contractor further agrees to include the substance of this clause in any subcontract, which may be awarded under this agreement.

 

H.2         Disclosure
of Information

 

H.2.1      Performance
under this agreement may require the Contractor to access non-public data and information proprietary to a Government agency, another
Government Contractor or of such nature that its dissemination or use other than as specified in the work statement would be adverse
to the interests of the Government or others. Neither the Contractor, nor Contractor personnel, shall divulge nor release data
nor information developed or obtained under performance of this agreement, except authorized by Government personnel or upon written
approval of the CO. The Contractor shall not use, disclose, or reproduce proprietary data that bears a restrictive legend, other
than as specified in this agreement or any information at all regarding this agency.

 

H.2.2      Consistent
with HHS Directive 1139, the Contractor shall comply with HHS requirements for protection of non-public information. Unauthorized
disclosure of nonpublic information is prohibited by the HHS’s rules. Unauthorized disclosure may result in termination of
the agreement, replacement of a Contractor employee, or other appropriate redress. Neither the Contractor nor the Contractor’s
employees shall disclose or cause to be disseminated, any information concerning the operations of the activity, which could result
in, or increase the likelihood of, the possibility of a breach of the activity’s security or interrupt the continuity of
its operations.

 

H.2.3       No
information related to data obtained under this agreement shall be released or publicized without the prior written consent of
the COR, whose approval shall not be unreasonably withheld, conditioned, or delayed, provided that no such consent is required
to comply with any law, rule, regulation, court ruling or similar order; for submission to any government entity, for submission
to any securities exchange on which the Contractor’s (or its parent corporation’s) securities may be listed for trading;
or to third parties relating to securing, seeking, establishing or

 

    	 	 	 

     

    

 

maintaining regulatory or other legal approvals or compliance,
financing and capital raising activities, or mergers, acquisitions, or other business transactions.

 

H.3         Confidentiality
of Information

 

a.                  Confidential information, as used in this article, means information or data of a personal
nature about an individual, or proprietary information or data submitted by or pertaining to an institution or organization.

 

b.                 The Agreements Officer and the Contractor may, by mutual consent, identify elsewhere in this
agreement specific information and/or categories of information which the Government will furnish to the Contractor or that the
Contractor is expected to generate which is confidential. Similarly, the Agreements Officer and the Contractor may, by mutual consent,
identify such confidential information from time to time during the performance of the agreement. Failure to agree will be settled
pursuant to the “Disputes” clause.

 

c.                  If it is established elsewhere in this agreement that information to be utilized under this
agreement, or a portion thereof, is subject to the Privacy Act, the Contractor will follow the rules and procedures of disclosure
set forth in the Privacy Act of 1974, 5 U.S.C. 552a, and implementing regulations and policies, with respect to systems of records
determined to be subject to the Privacy Act.

 

d.                  Confidential information, as defined in paragraph (a) of this article, shall not be disclosed
without the prior written consent of the individual, institution, or organization.

 

e.                   Whenever the Contractor is uncertain with regard to the proper handling of material under
the agreement, or if the material in question is subject to the Privacy Act or is confidential information subject to the provisions
of this article, the Contractor shall obtain a written determination from the Agreements Officer prior to any release, disclosure,
dissemination, or publication.

 

f.                   Agreements Officer Determinations will reflect the result of internal coordination with appropriate
program and legal officials.

 

g.                 The provision of paragraph (d) of this article shall not apply to conflicting or overlapping
provisions in other Federal, State or local laws.

 

All above requirements MUST be passed to
all sub-contractors.

 

H.4         Organizational
Conflicts of Interest

 

H.4.1      Performance
under this agreement may create an actual or potential organizational conflict of interest such as are contemplated by FAR Part
9.505-General Rules. The Contractor shall not engage in any other contractual or other activities which could create an organizational
conflict of interest (OCI). This provision shall apply to the prime Contractor and all sub-Contractors. This provision shall have
effect throughout the period of performance of this agreement, any extensions thereto by change order or supplemental agreement,
and for two (2) years thereafter. The Government may pursue such remedies as may be permitted by law or this agreement, upon determination
that an OCI has occurred.

 

H.4.2      The
work performed under this agreement may create a significant potential for certain conflicts of interest, as set forth in FAR Parts
9.505-1, 9.505-2, 9.505-3, and 9.505-4. It is the intention of the parties hereto to prevent both the potential for bias in connection
with the Contractor’s performance of this agreement, as well as the creation of any unfair competitive advantage as a result
of knowledge gained through access to any non-public data or third party proprietary information.

 

H.4.3      The
Contractor shall notify the Agreements Officer immediately whenever it becomes aware that such access or participation may result
in any actual or potential OCI. Furthermore, the Contractor shall promptly submit a plan to the Agreements Officer to either avoid
or mitigate any such OCI. The Agreements Officer will have sole discretion in accepting the Contractor’s mitigation plan.
In the event the Agreements Officer unilaterally determines that any

 

    	 	 	 

     

    

 

such OCI cannot be satisfactorily avoided or mitigated, other
remedies may be taken to prohibit the Contractor from participating in agreement requirements related to OCI.

 

H.4.4       Whenever
performance of this agreement provides access to another Contractor’s proprietary information, the Contractor shall:

 

(1)                enter into a written agreement with the other entities involved, as appropriate, in order
to protect such proprietary information from unauthorized use or disclosure for as long as it remains proprietary; and refrain
from using such proprietary information other than as agreed to, for example to provide assistance during technical evaluation
of other Contractors’ offers or products under this agreement. An executed copy of all proprietary information agreements
by individual personnel or on a corporate basis shall be furnished to the CO within fifteen (15) calendar days of execution.

 

H.5         Operations
Security (OPSEC)

 

H.5.1       The
Contractor shall develop and submit an OPSEC Standing Operating Procedure (SOP) Plan within thirty (30) calendar days of agreement
award, to be reviewed and approved by the Government OPSEC lead for this effort. The final OPSEC plan must address the Government’s
identified Critical Information List (CIL).

		a)	All contractors supporting this effort must complete OPSEC Computer Based Training (CBT) that can
be accessed via the (Insert applicable website here).

 

H.6         Security

 

H.6.1      The
Contractor shall develop a comprehensive security program that provides overall protection of personnel, information, data, and
facilities associated with fulfilling the BARDA requirement. This plan shall establish security practices and procedures that demonstrate
how the Contractor will meet and adhere to the security requirements outlined below prior to the commencement of product manufacturing,
and shall be delivered to the Government within thirty (30) days of award. The Contractor shall also ensure all subcontractors,
consultants, researchers, etc. performing work on behalf of this effort, comply with all BARDA security requirements and prime
contractor security plans.

		a)	ASPR will review in detail and submit comments within ten (10) business days to the Agreements
Officer (CO) to be forwarded to the Contractor. The Contractor shall review the Draft Security Plan comments, and, submit a Final
Security Plan to the U.S. Government within thirty (30) calendar days after receipt of the comments.

		b)	The Security Plan shall include a timeline for compliance of all the required security measures
outlined by BARDA.

		c)	Upon completion of initiating all security measures, the Contractor shall supply to the Agreements
Office a letter certifying compliance to the elements outlined in the Final Security Plan.

 

H.6.2       At
a minimum, the Final Security Plan shall address the following items:

 

BARDA SECURITY REQUIREMENTS

	
1.  Facility
Security Plan

        Description: As part of the partner facility’s
        overall security program, the Contractor shall submit a written security plan with their proposal to BARDA for review and approval
        by BARDA security subject matter experts. The performance of work under the BARDA agreement will be in accordance with the approved
        security plan. The security plan will include the following processes and procedures at a minimum.

	Security Administration	
●  organization
chart and responsibilities

●  written
security risk assessment for site

●  threat
levels with identification matrix (High, Medium, or Low)

●  enhanced
security procedures during elevated threats

●  liaison
procedures with law enforcement

●  annual
employee security education and training program

	Personnel Security	
●  policies
and procedures

●  candidate
recruitment process

●  background
investigations process

 

    	 	 	 

     

    

 

	 	●  employment suitability policy

●  employee access determination

●  rules of behavior/conduct

●  termination procedures

●  non-disclosure agreements

	Physical Security Policies and Procedures	
●  internal/external
access control

●  protective
services

●  identification/badging

●  employee
and visitor access controls

●  parking
areas and access control

●  perimeter
fencing/barriers

●  product
shipping, receiving and transport security procedures

●  facility
security lighting

●  restricted
areas

●  signage

●  intrusion
detection systems

●  alarm
monitoring/response

●  closed
circuit television

●  product
storage security

●  other
control measures as identified

	Information Security	
●  identification
and marking of sensitive information

●  access
control

●  storage
of information

●  document
control procedures

●  retention/destruction
requirements

	Information

Technology/Cyber Security Policies and Procedures	
●  intrusion
detection and prevention systems

●  threat
identification

●  employee
training (initial and annual)

●  encryption
systems

●  identification
of sensitive information/media

●  password
policy (max days 90)

●  lock
screen time out policy (minimum time 20 minutes)

●  removable
media policy

●  laptop
policy

●  removal
of IT assets for domestic/foreign travel

●  access
control and determination

●  VPN procedures

●  Wi-Fi
and Bluetooth disabled when not in use

●  system
document control

●  system
backup

●  system
disaster recovery

●  incident
response

●  system
audit procedures

●  property
accountability

	
2.  Site Security
Master Plan

        Description: The partner facility shall
        provide a site schematic for security systems which includes: main access points; security camera;, electronic access points; IT
        Server Room; Product Storage Freezer/Room; and bio-containment laboratories.

	 	 
	
3.  Site Threat/Vulnerability/Risk
Assessment

        Description: The partner facility shall
        provide a written risk assessment for the facility addressing: criminal threat, including crime data; foreign/domestic terrorist
        threat; industrial espionage; insider threats; natural disasters; and 

 

    	 	 	 

     

    

 

	potential loss of critical infrastructure (power/water/natural
        gas, etc.). This assessment shall include recent data obtained from local law enforcement agencies. This assessment should be updated
        annually.
	 	 
	
4.  Physical
Security

        Description:

	Closed Circuit Television (CCTV) Monitoring	
        a)      
        Layered (internal/external) CCTV coverage with time-lapse video recording for buildings and
        areas where critical assets are processed or stored.

        b)     
        CCTV coverage must include entry and exits to critical facilities, perimeters, and areas within
        the facility deemed critical to the execution of the agreement.

        c)     
        Video recordings must be maintained for a minimum of 30 days.

        d)     
        CCTV surveillance system must be on emergency power backup.

        e)     
        CCTV coverage must include entry and exits to critical facilities, perimeters, and areas within
        the facility deemed critical to the execution of the agreement.

        f)      
        Video recordings must be maintained for a minimum of 30 days.

        g)     
        CCTV surveillance system must be on emergency power backup.

	Facility Lighting	
        a)     
        Lighting must cover facility perimeter, parking areas, critical infrastructure, and entrances
        and exits to buildings.

        b)     
        Lighting must have emergency power backup.

        c)    
         Lighting must be sufficient for the effective operation of the CCTV
        surveillance system during hours of darkness.

	Shipping and Receiving	
        a)     
        Must have CCTV coverage and an electronic access control system.

        b)     
        Must have procedures in place to control access and movement of drivers picking up or delivering
        shipments.

        c)     
        Must identify drivers picking up BARDA products by government issued photo identification.

	Access Control	
        a)     
        Must have an electronic intrusion detection system with centralized monitoring.

        b)     
        Responses to alarms must be immediate and documented in writing.

        c)     
        Employ an electronic system (i.e., card key) to control access to areas where assets critical
        to the agreement are located (facilities, laboratories, clean rooms, production facilities, warehouses, server rooms, records storage,
        etc.)

        d)    
        The electronic access control should signal an alarm notification of unauthorized attempts
        to access restricted areas.

        e)     
        Must have a system that provides a historical log of all key access transactions and kept on record for a minimum of 12
        months.

        f)     
        Must have procedures in place to track issuance of access cards to employees and the ability
        to deactivate cards when they are lost or an employee leaves the company.

        g)      Response
        to electronic access control alarms must be immediate and documented in writing and kept on record for a minimum of 12
        months.

        h)    
        Should have written procedures to prevent employee piggybacking access.

        i)      
        to critical infrastructure (generators, air handlers, fuel storage, etc.) should be controlled
        and limited to those with a legitimate need for access.

        j)      
        Must have a written manual key accountability and inventory process.

        k)    
        Physical access controls should present a layered approach to critical assets within the facility.

	
        Employee/Visitor

        Identification
	
        a)     
        Should issue company photo identification to all employees.

        b)   
        Photo identification should be displayed above the waist anytime the employee is on company
        property.

        

 

    	 	 	 

     

    

 

	 	c)     Visitors should be sponsored by an employee and must present government issued photo identification to enter the property. 

d)     Visitors should be logged in and out of the facility and should be escorted by an employee while on the premises at all times.

	Security Fencing	Requirements for security fencing will be determined by the criticality of the program, review of the security plan, threat assessment, and onsite security assessment.
	Protective Security Forces	Requirements for security offices will be determined by the criticality of the program, review of the security plan, threat assessment, and onsite security assessment.
	Protective Security Forces Operations	
        a)     
        Must have in-service training program.

        b)     
        Must have Use of Force Continuum.

        c)     
        Must have communication systems available (i.e., landline on post, cell phones, handheld radio,
        and desktop computer).

        d)     
        Must have standing Post Orders.

        e)     
        Must wear distinct uniform identifying them as security officers.

	
5.  Security
Operations

        Description:

	Information Sharing	
        a)     
        Establish formal liaison with law enforcement.

        b)    
        Meet in person at a minimum annually. Document meeting notes and keep them on file for a minimum
        of 12 months. POC information for LE Officer that attended the meeting must be documented.

        c)     
        Implement procedures for receiving and disseminating threat information.

	Training	
        a)     
        Conduct new employee security awareness training.

        b)     
        Conduct and maintain records of annual security awareness training.

	Security Management	
        a)     
        Designate a knowledgeable security professional to manage the security of the facility.

        b)     
        Ensure subcontractor compliance with all BARDA security requirements.

	
6.  Personnel
Security

        Description:

	Records Check	Verification of social security number, date of birth, citizenship, education credentials, five-year previous employment history, five-year previous residence history, FDA disbarment, sex offender registry, credit check based upon position within the company; motor vehicle records check as appropriate; and local/national criminal history search.
	
        Hiring and Retention

        Standards
	
        a)     
        Detailed policies and procedures concerning hiring and retention of employees, employee conduct,
        and off boarding procedures.

        b)    
        Off Boarding procedures should be accomplished within 24 hours of employee leaving the company.
        This includes termination of all network access.

	
7.  Information
Security

        Description:

	Physical Document Control	
        a)     
        Applicable documents shall be identified and marked as procurement sensitive, proprietary,
        or with appropriate government markings.

        b)   
        Sensitive, proprietary, and government documents should be maintained in a lockable filing
        cabinet/desk or other storage device and not be left unattended.

        c)    
        Access to sensitive information should be restricted to those with a need to know.

	Document Destruction	Documents must be destroyed using approved destruction measures (i.e., shredders/approved third party vendors/pulverizing/incinerating).
	
8.  Information
Technology & Cybersecurity

        Description:

 

    	 	 	 

     

    

 

	Identity Management	
        a)     
        Physical devices and systems within the organization are inventoried and accounted for annually.

        b)     
        Organizational cybersecurity policy is established and communicated.

        c)     
        Asset vulnerabilities are identified and documented.

        d)     
        Cyber threat intelligence is received from information sharing forums and sources.

        e)     
        Threats, vulnerabilities, likelihoods, and impacts are used to determine risk.

        f)      
        Identities and credentials are issued, managed, verified, revoked, and audited for authorized
        devices, users and processes.

        g)    
        Users, devices, and other assets are authenticated (e.g., single-factor, multifactor) commensurate
        with the risk of the transaction (e.g., individuals’ security and privacy risks and other organizational risks).

	Access Control	
        a)    
        Limit information system access to authorized users.

        b)    
        Identify information system users, processes acting on behalf of users, or devices and authenticate
        identities before allowing access.

        c)    
        Limit physical access to information systems, equipment, and server rooms with electronic
        access controls.

        d)    
        Limit access to/verify access to use of external information systems.

	Training	a)     Ensure that personnel are trained and are made aware of the security risks associated with their activities and of the applicable laws, policies, standards, regulations, or procedures related to information technology systems.
	Audit and Accountability	
        a)    
        Create, protect, and retain information system audit records to the extent needed to enable
        the monitoring, analysis, investigation, and reporting of unlawful, unauthorized, or inappropriate system activity. Records must
        be kept for minimum must be kept for 12 months.

        b)     
        Ensure the actions of individual information system users can be uniquely traced to those
        users.

        c)     
        Update malicious code mechanisms when new releases are available.

        d)     
        Perform periodic scans of the information system and real time scans of files from external
        sources as files are downloaded, opened, or executed.

	Configuration Management	
        a)     
        Establish and enforce security configuration settings.

        b)     
        Implement sub networks for publicly accessible system components that are physically or logically
        separate from internal networks.

	Contingency Planning	a)     Establish, implement, and maintain plans for emergency response, backup operations, and post-disaster recovery for information systems to ensure the availability of critical information resources at all times.
	Incident Response	a)     Establish an operational incident handling capability for information systems that includes adequate preparation, detection, analysis, containment, and recovery of cybersecurity incidents.  Exercise this capability annually.
	Media and Information Protection	
        a)     
        Protect information system media, both paper and digital.

        b)     
        Limit access to information on information systems media to authorized users.

        c)     
        Sanitize and destroy media no longer in use.

        d)     
        Control the use of removable media through technology or policy.

	Physical and Environmental Protection	
        a)    
        Limit access to information systems, equipment, and the respective operating environments
        to authorized individuals.

        b)     
        Intrusion detection and prevention system employed on IT networks.

        c)     
        Protect the physical and support infrastructure for all information systems.

        d)     
        Protect information systems against environmental hazards.

        e)     
        Escort visitors and monitor visitor activity.

 

    	 	 	 

     

    

 

	Network Protection	Employ intrusion prevention and detection technology with immediate analysis capabilities.
	
9.  Transportation
Security

        Description: Adequate security controls
        must be implemented to protect materials while in transit from theft, destruction, manipulation, or damage.

	Drivers	
        a)     
        Drivers must be vetted in accordance with BARDA Personnel Security Requirements.

        b)     
        Drivers must be trained on specific security and emergency procedures.

        c)     
        Drivers must be equipped with backup communications.

        d)     
        Driver identity must be 100 percent confirmed before the pick-up of any BARDA product.

        e)     
        Drivers must never leave BARDA products unattended, and two drivers may be required for longer
        transport routes or critical products during times of emergency.

        f)      
        Truck pickup and deliveries must be logged and kept on record for a minimum of 12 months.

	Transport Routes	
        a)     
        Transport routes should be pre-planned and never deviated from except when approved or in
        the event of an emergency.

        b)    
        Transport routes should be continuously evaluated based upon new threats, significant planned
        events, weather, and other situations that may delay or disrupt transport.

	Product Security	
        a)     
        BARDA products must be secured with tamper resistant seals during transport, and the transport
        trailer must be locked and sealed.

        ·     
        Tamper resistant seals must be verified as “secure” after the product is placed
        in the transport vehicle.

        b)     
        BARDA products should be continually monitored by GPS technology while in transport, and any
        deviations from planned routes should be investigated and documented.

        c)     
        Contingency plans should be in place to keep the product secure during emergencies such as
        accidents and transport vehicle breakdowns.

	
10.  Security
Reporting Requirements

        Description: The partner facility shall
        notify the BARDA Security Team within 24 hours of any activity or incident that is in violation of established security standards
        or indicates the loss or theft of government products. The facts and circumstances associated with these incidents will be documented
        in writing for government review.

	 	 
	
11.  Security
Audits

        Description: The partner facility agrees
        to formal security audits conducted at the discretion of the government. Security audits may include both prime and subcontractor.

	 	 

 

    	 	 	 

     

    

 

Section 1 – Contract Clauses

 

TERMS & CONDITIONS

 

TECHNOLOGY INVESTMENT AGREEMENT

 

between

 

Retractable Technologies, Inc.(RTI)

 

and

 

Department of Defense,

U.S. Army Contracting Command –
Aberdeen Proving Ground,

Natick Contracting Division & Edgewood
Contracting Division

(ACC-APG, NCD & ECD)

 

on behalf of

 

Biomedical Advanced Research and Development
Authority (BARDA)

 

for

 

Expanding Domestic Production of Needles
 & Syringes

 

 

 

Agreement No.: W911SR2030004

Total Amount of Government Funding for the
Agreement: $53,644,286

Total Cost Share for the Agreement: [$53,644,286]

Total Estimated Value of the Agreement: [$107,328,572]

Effective Date: 01 JUL 2020

 

    	 	 	 

     

    

 

TECHNOLOGY INVESTMENT AGREEMENT TERMS
AND CONDITIONS

 

 

ARTICLES

		1.	Scope of Agreement

		2.	Term of Agreement

		3.	Order of Precedence

		4.	Program/Administrative Management

		5.	Financial Management & Payment

		6.	Accounting & Audit

		7.	Purchasing & Title

		8.	Cost Sharing

		9.	Government Preference

		10.	Records Retention & Government Access

		11.	Intellectual Property & Patent Rights

		12.	Data Rights

		13.	FDA Regulatory Requirements

		14.	Termination

		15.	Disputes

		16.	Reports & Distribution

		17.	Modification

		18.	Miscellaneous

 

 

 

[ATTACHMENTS

 

		A.	Recipient’s Proposal (Final Project Plan
dated 18 JUN 2020)

 

		B.	Collaboration Plan (Statement of Objectives
[SOO] dated 22 JUN 2020) ]

 

    	 	 	 

     

    

 

RECITALS

 

This Agreement is entered
into between the United States of America, Department of Defense, represented by ACC-APG, NCD & ECD ("Government")
and Retractable Technologies, Inc. (RTI), ("Recipient"), collectively referred to as the "Parties,'' pursuant to
and under the statutory authority at 10 U.S.C. §2371 and/or 10 U.S.C. §2358.

 

The Recipient, a for-profit
firm, submitted a basic, applied, or advanced research proposal to the Government in response to the publicly disseminated Medical
Countermeasures System (MCS) Broad Agency Announcement (BAA) 17-01. The proposal was identified within the MCS BAA scope of: Advanced
Development & Manufacturing Capabilities (ADMC), to develop a national capability and capacity to develop and produce medical
countermeasures rapidly to counter known or unknown chemical, biological, radioactive, and nuclear (CBRN) threats, including novel
and previously unrecognized, naturally-occurring emerging infectious diseases such as the COVID-19 virus. The specific MCS BAA
Area of Interest is Mission Area I, Medical Biological Prophylaxis.

 

The Government awards
this Technology Investment Agreement (TIA) to fund the Recipient proposal subject to the following terms and conditions and other
statutory requirements. The Parties desire to enter into this Agreement to establish said terms and conditions under which they
plan to carry out the research and other activities as described below.

 

THEREFORE, THE PARTIES AGREE:

 

		1.	Scope of Agreement

 

		1.1	Governing Authority

 

This Technology Investment
Agreement (TIA) is an assistance transaction other than a grant or cooperative agreement and is awarded pursuant to 10 USC §2371
and/or 10 USC §2358, as applicable, as implemented by 32 Code of Federal Regulations (CFR) Part 37, and Parts 22 and 34 where
specifically referenced. The following are also incorporated in full: Definitions at Subpart J of 32 CFR Part 37; National Policies
at Appendix B, 32 CFR Part 22; Audits at Appendix C of 32 CFR Part 37. This TIA is subject to good manufacturing practices (cGMPS)
at 21 CFR 210 and 211, as applicable. The Federal Acquisition Regulation (FAR), Defense Federal Acquisition Regulation Supplement
(DFARS), DoD Grant and Agreement Regulations (DoDGARs), or other regulatory and statutory requirements apply as specifically referenced
herein. If this instrument is awarded under the authority at 10 USC §2358, the Bayh-Dole Act, 35 U.S.C. §§200-212
applies, as applicable.

 

		1.2	Principal Purpose

 

The Government and
the Recipient agree that the principal purpose of this Agreement is for Government investment into the development/expansion of
Recipient's manufacturing capacity for hypodermic safety needles and corresponding syringes in response to the worldwide Coronavirus
(COVID-19) global pandemic [as described in RTI's proposal entitled "Increasing U.S.
Manufacturing Capacity of Essential Healthcare Supplies'', dated 18 JUNE 2020, hereinafter, the "Plan" or "Project".
This effort shall be carried out as set forth in the Recipient's Plan and subsequent revisions, which are hereby incorporated in
their entirety]. This Agreement is not intended to be, nor shall it be construed as, by implication or otherwise, a partnership,
a corporation, or other business organization.

 

    	 	 	 

     

    

 

		2.	Term of Agreement

 

This Agreement shall
commence upon the effective date listed on page 1, after execution of the Agreement by both parties, for a period of 10 years,
the “term” of the Agreement or “Period of Performance.” Period of performance means the time during
which a recipient or sub-recipient may incur new obligations to carry out the work authorized under an award or sub-award, respectively.

 

		3.	Order of Precedence

 

This Agreement is subject
to the laws and regulations of the United States. In the event of a conflict or inconsistency in the terms and conditions or attachments
specified in this Agreement, the conflict or inconsistency shall be resolved according to the following order of precedence: (a)
the Federal statute authorizing this award, or any other Federal statutes directly affecting performance of this Agreement, including
attachments where applicable; (b) Federal regulations specifically referenced;(c) the terms and conditions contained within the
Agreement, including any documents incorporated; (d) programmatic requirements.

 

		4.	Program/Administrative Management

 

4.1              
Program Management

 

The Recipient has full
responsibility for the project/activity supported by this Agreement, in accordance with the Recipient's proposal and proposal revisions/appendices,
and the terms and conditions specified in this Agreement. The Government will have continuous and/or substantial involvement with
the Recipient pursuant to a Collaboration Plan as incorporated. The Recipient must consult the Program Office/Technical Representative
through the Agreements Officer before deviating from the objectives or overall program of the research originally proposed. Non-compliance
with any award provision of this clause may result in the withholding of funds and or the termination of the award.

 

4.2              
Government Representatives:

 

Agreements Officer (AO)

[John
Conlin

ACC-APG,
NCD

1
General Greene Avenue

Natick,
MA 01760

508-206-2064

john.conlin3.civ@usa.army.mil]

 

Agreements Specialist (AS)

[Mackenzie
Martz]

ACC-APG, ECD

8456 Brigade Street

Building E4215

Aberdeen Proving Ground, MC 21010

[301-619-8518

mackenzie.t.martz.civ@mail.mil]

 

    	 	 	 

     

    

 

Administrative Grants Officer (AGO)

DCMA DALLAS -S4402A

4211 Cedar Springs Road

Dallas, TX 75219

[214-670-9201

dcma.lee.hq.list.s4402a-casd@mail.mil]

 

Biomedical Advanced Research and
Development Authority (BARDA) Program

Manager (PM)

[Joseph
Figlio

Assistant
Secretary for Preparedness and Response (ASPR)/BARDA

Room
23E07 – O’Neill House Office Building

Washington,
DC 20515

202-480-0145

joseph.figlio@hhs.gov]

 

4.3              
Recipient’s Representatives

 

[Kathryn
Duesman

Registered
Nurse (RN), Vice President of Clinical Affairs

RTI

511
Lobo Lane

Little
Elm, TX 75068

972-294-1010

RTIclinical@vanishpoint.com

 

Larry
Salerno

Director
of Operations

RTI

511
Lobo Lane

Little
Elm, TX 75068

972-294-1010

RTIops@vanishpoint.com]

 

		5.	Financial Management & Payment

 

5.1              
Expenditure-Based.

 

This Agreement is an
expenditure type TIA as described in 32 CFR §37.1285. Expenditure is defined in 32 CFR §37.1290. The charges may
be reported on a cash or accrual basis, as long as the methodology is disclosed and is consistently applied. In accordance with
32 CFR 37.300(a): "For an expenditure-based TIA, the amounts of interim payments or the total amount ultimately paid to the
Recipient are based on the amounts the Recipient expends on project costs. If a Recipient completes the project specified at the
time of award before it expends all of the agreed-upon Federal funding and Recipient cost sharing, the Federal Government may recover
its share of the unexpended balance or, by mutual agreement with the Recipient, amend the agreement to expand the scope of the
research project. An expenditure-based TIA therefore is analogous to a cost-type procurement contract or grant.”

 

Payments shall be made
on a monthly basis for expenditures incurred up to the agreed upon project ceiling & Government investment funding amount,
for the duration of the Period of Performance.

 

    	 	 	 

     

    

 

5.2              
Obligation

 

In no case shall the
Government’s financial obligation exceed the amount obligated on this Agreement or by amendment to the Agreement. The Government
is not obligated to reimburse the Recipient for expenditures in excess of the amount of obligated funds allotted by the Government.

 

5.3              
Wide Area Workflow. The following guidance is provided for invoicing processed under this
Agreement through WAWF:

 

5.3.1         
Acceptance within the WAWF system shall be performed by the AGO upon receipt of a confirmation
email, or other form of transmittal, from the BARDA PM.

 

5.3.2         
The Recipient shall send an email notice to the BARDA PM and upload the BARDA PM approval
as an attachment upon submission of an invoice in WAWF (this can be done from within WAWF).

 

5.3.3         
Payments shall be made by the Defense Finance and Accounting services (DFAS) office indicated
below within thirty (30) calendar days of an accepted invoice in WAWF.

 

5.3.4         
WAWF Provision:

 

(a)        Definitions.
As used in this clause –

 

Department of Defense Activity
Address Code (DoDAAC) is a six-position code that uniquely identified a unit, activity, or organization.

 

Document type means the type
of payment request or receiving report available for creation in Wide Area WorkFlow (WAWF).

 

Local processing office (LPO)
is the office responsible for payment certification when payment certification is done external to the entitlement system.

 

(b)        Electronic
invoicing. The WAWF system is the method to electronically process vendor payment requests and receiving reports, as authorized
by DFARS 252.232-7003, Electronic Submission of Payment Requests and Receiving Reports.

 

(c)        WAWF
access. To access WAWF, the Recipient shall (i) have a designated electronic business point of contact in the System for Award
Management at https://www.acquisition.gov; and (ii) be registered to use WAWF at https://wawf.eb.mil/ following the step-by-step
procedures for self-registration available at this website.

 

(d)        WAWF
training. The Recipient should follow the training instructions of the WAWF Web-Based Training Course and use the Practice Training
Site before submitting payment requests through WAWF. Both can be accessed by selecting the “Web Based Training” link
on the WAWF home page at https://wawf.eb.mil/.

 

(e)        WAWF
methods of document submission. Document submissions may be via Web entry, Electronic Data Interchange, or File Transfer Protocol.

 

(f)        WAWF
payment instructions. The Recipient must use the following information when submitting payment requests and receiving reports in
WAWF for this contract/order:

 

    	 	 	 

     

    

 

(1)                
Document type. The Recipient shall use the following document type: Invoice and Receiving
Report (Combo).

 

(2)               
Inspection/acceptance location. The Recipient shall select the following inspection/acceptance
location(s) in WAWF, as specified by the contracting officer.

 

(3)                
Document routing. The Recipient shall use the information in the Routing Data Table below
only to fill in applicable fields in WAWF when creating payment requests and receiving reports in the system.

 

Routing Data Table*

 

	Field Name in WAWF	Data to be entered in WA
	Pay Official DoDAAC	HQ0339
	Issue by DoDAAC	W911SR
	Admin DoDAAC	S4402A
	Inspect by DodAAC	W56XNH
	Ship to Code	W56XNH

 

Payee Information: As identified
at the System for Award Management.

 

		·	RTI

		·	Cage Code: 1BFK3

		·	DUNS: 838024255

 

(4)                
Payment request and supporting documentation. The Recipient shall ensure a payment request
includes appropriate contract line item and subline item descriptions of the work performed or supplies delivered, unit price/cost
per unit, fee (if applicable), and all relevant back-up documentation in support of each payment request.

 

(5)                
WAWF email notifications. The Recipient shall enter the email address identified below in
the "Send Additional Email Notifications" field of WAWF once a document is submitted in the system.

 

(g)       WAWF
point of contact.

 

(1)               
The Recipient may obtain clarification regarding invoicing in WAWF from the following contracting
activity’s WAWF point of contact.

 

Administrative
Grants Officer (AGO)

DCMA DALLAS
-S4402A

4211 Cedar Springs Road

Dallas, TX 75219

214-670-9201

[dcma.lee.hq.list.s4402a-casd@mail.mil]

 

    	 	 	 

     

    

 

(2)               
For technical WAWF help, contact the WAWF helpdesk at 866-618-5988.

 

		6.	Accounting & Audit

 

6.1              
Accounting System.

 

6.1.1.       
The Recipient's systems must demonstrate effective control of all funds. Control systems must
be adequate to ensure that costs charged to Federal funds and those counted as the Recipient's cost share or match are consistent
with requirements for cost reasonableness, allowability, and allocability as set forth in 32 CFR §37.625(b) and in the terms
and conditions of the award. The Recipient must be able to provide accurate, current and complete records that document for work
funded wholly or in part with Federal funds, the source and application of the Federal funds and the Recipient has required cost
share or match.

 

6.1.2.    
The Recipient's cost accounting system shall be in compliance with Generally Accepted Accounting
Principles (GAAP) in accordance with 32 CFR §37.615. The system must effectively control all Project funds, including Federal
funds and any required cost share. The system must have complete, accurate, and current records that document the sources of funds
and the purposes for which they are disbursed. It also must have procedures for ensuring that Project funds are used only for purposes
permitted by the agreement (§37.625).

 

6.2   
Annual Audit Requirement.

 

The Recipient shall
have an annual audit performed by the Defense Contract Audit Agency (DCAA), or, an independent auditor, in accordance with 32 CFR
 §37.650. It is preferable that DCAA conduct the audit if the Recipient will grant DCAA access to information and records required
to complete the audit. The Recipient shall provide a copy of the auditor's report to the AO within 60-days after audit.

 

6.3              
Program Income. Program income derived during the initial Period of Performance from Government
funding shall be allocated to finance the non-Federal share of the Project (including the amounts described in Section 8.1) in
accordance with 32 CFR §34.14(d)(2). As contemplated by 32 CFR §34.14(b)(2), Recipient will have no obligation to the
Government for program income generated after the end of the Period of Performance, and no recover of funds is contemplated under
32 CFR §37.580.

 

		7.	Purchasing & Title

 

7.1        Title
to Property Acquired under Agreement. Title to real property, equipment, and supplies or intangible property that are acquired
by the Recipient (whether by purchase, construction or fabrication, development, or otherwise) with Government funding vests in
the Recipient conditionally as described at 32 CFR 37.685.

 

7.2              
Disposition. Any Federal interest in the real property or equipment remaining after the term
will be addressed at the time of property disposition. Disposition will be in accordance with 32 CFR 34.21.

 

7.3             
Purchasing System. If the Recipient currently performs under DoD assistance instruments subject
to the purchasing standards in 32 CFR 34.31, then that Part applies. Otherwise, the Recipient may use the existing purchasing systems,
as long as applicable requirements are flowed down (37.705).

 

    	 	 	 

     

    

 

		8.	Cost Sharing

 

8.1       To
the maximum extent practicable, the recipient must provide at least [half] of the
costs of the project, in accordance with §37.215. Total value of the TIA means the total amount of costs that are currently
expected to be charged to the award over its life, which includes amounts for the Federal share and any non-Federal cost sharing
or matching required under the award; and any options, even if not yet exercised, for which the costs have been established in
the award.

 

8.2        
The Government funding is estimated to represent approximately [50%]
of the overall amount necessary to accomplish the scope of work cited in the proposal (inclusive of all proposal revisions and
appendices). The Recipient agrees to provide the resources in the manner shown in their proposal. Recipient's cost sharing contribution
will occur within the term of the agreement but may not coincide with the Government's expenditure payments.

 

8.3        
Failure of either Party to provide its respective total contribution may result in a unilateral
modification to this Agreement by the AO to reflect proportional reduction in funding for the other Party.

 

		9.	Government Preference

 

[9.1       Pricing.
For a period of three (3) years following construction, installation and startup of commercial production for VanishPoint 1 mL,
VanishPoint 3 mL syringes and EasyPoint needles made by Recipient on machines funded by the U.S. Government ("Products")
Recipient agrees not to knowingly offer or sell such Products to any other U.S. purchaser for a unit price less than that offered
to the U.S. Government by Recipient with the exception of sales under contractual price agreements executed prior to the effective
date of this Agreement. In the event that Recipient, without prior written agreement by the Agreements Officer, makes a material
sale of Products to another U.S. purchaser at a unit price lower than that offered by Recipient to the U.S. Government, Recipient
shall promptly notify the Agreements Officer of the lower unit price of Products sold. Recipient shall also promptly apply the
difference in unit price against the unit price quoted to the U.S. Government for Products then on order or subsequently ordered
from Recipient within the three-year period. For a period of 10 years following construction, installation and startup of commercial
production for VanishPoint 1 mL, VanishPoint 3 mL syringes and EasyPoint needles should any other public health emergency be declared,
the aforementioned preferred pricing shall be in effect for up to three (3) years upon declaration of public health emergency.]

 

9.2       Precedence.
Recipient agrees that upon Presidential Declaration of a Public Health Emergency, that Government orders will be provided precedence
for completion on machines funded by the U.S. Government over and above any other orders. This requirement applies regardless of
a DO or DX rating under the Defense Production Act.

 

9.3       Maintenance
of equipment and availability of capacity. Recipient agrees that for a period of 10 years following the commissioning of equipment
funded by this Agreement, that it shall maintain the equipment in such a way as to ensure that, should the rights established under
9.1 and 9.2 be in effect, there is capacity equal to that which was available at time of commissioning. Further, the Recipient
agrees that should the equipment funded by this agreement be unavailable during a period in which the rights under 9.l and 9.2
are in effect, the Recipient will make available to the Government equivalent capacity from equipment not funded under this agreement.

 

9.4.      Inspection
of equipment. The Recipient grants the Government the right to inspect at any time, upon provision of reasonable advance notice,
the equipment funded by this agreement. This right shall be in effect for l 0 years following commissioning of the equipment.

 

    	 	 	 

     

    

 

		10.	Records Retention & Government Access

 

The DoD, Comptroller
General of the United States, or any of their duly authorized representatives, have the right of timely and unrestricted access
to any books, documents, papers, or other records of the Recipient that are pertinent solely to the Recipient's technical performance
under this Agreement, in order to make examinations, excerpts, transcripts and copies of such documents. This right also includes
timely and reasonable access to the Recipient's personnel for the purpose of interview and discussion related to such records.
Such access shall be performed during business hours on business days upon written notice and shall be subject to the security
requirements of the audited Party to the extent such security requirements do not conflict with the rights of access otherwise
granted by this paragraph. The rights of access in this paragraph shall last as long as records are retained. The rights of access
in this paragraph do not extend to the Recipient's financial records.

 

		11.	Intellectual Property & Patent Rights

 

11.1          
Background IP and Materials. The Recipient and the Government each retain any intellectual
property (IP) rights to their own materials, data, technology, information, documents, or know-how – or potential rights,
such as issued patents, patent applications, invention disclosures, or other written documentation – that exist prior to
execution of this Agreement or are developed outside the scope of this Agreement (Background IP).

 

11.2          
Authorization and Consent for Non-commercial Products. The Government authorizes and consents
to all use and manufacture, in performance of this Agreement, of any invention described in and covered by a United States patent,
except for deliverables under this Agreement that are commercially available to the public by the Recipient.

 

11.3          
Ownership. Ownership of any invention, regardless of whether it is not patentable, held as
a trade secret or is patentable under U.S. patent law that is conceived or first reduced to practice under this Agreement will
follow inventorship in accordance with U.S. patent law. The Parties represent and warrant that each inventor will assign his or
her rights in any such inventions to his or her employing organization.

 

11.4          
Patent Applications. Irrespective of any Disclosure of Information clauses in this Agreement
the Parties will respectively have the option to file a patent application claiming any Invention made solely by their respective
employees. The Parties will consult with each other regarding the options for filing a patent application claiming a joint Invention.
Within two (2) months of being notified of the discovery of an invention or filing a patent application covering an Invention,
each Party will provide notice of such discovery or filing to the other Party. The Parties will reasonably cooperate with each
other in the preparation, filing, and prosecution of any patent application claiming an Invention. Any Party filing a patent application
will bear expenses associated with filing and prosecuting the application, as well as maintaining any patents that issue from the
application, unless otherwise agreed by the Parties.

 

11.5          
Licenses. Upon the Recipient's request, the Government agrees to enter into good faith negotiations
regarding a non-exclusive commercialization license covering the Government's interest in any Invention made in whole or in part
by a Government employee. Any Invention made by a Recipient employee is subject to a nonexclusive, nontransferable, irrevocable,
paid-up license for the Government to practice and have practiced the Invention.

 

11.6          
Executive Order No. 9424 of 18 February 1944 requires all executive Departments and agencies
of the Government to forward through appropriate channels to the Commissioner of Patents and Trademarks, for recording, all Government
interests in patents or applications for patents. Should any of these provisions be inconsistent with the Bayh-Dole Act, the statute
takes precedence.

 

    	 	 	 

     

    

 

		12.	Data Rights

 

12.1          
All data generated in connection with the performance of the studies under this Agreement,
or that arises out of the use of any materials or enabling technology provided or used by the Recipient in the performance of this
Agreement, other materials or confidential information, whether conducted by the Government or the Recipient (collectively, the
 "Study Data"), shall be owned by the Recipient. The Government shall have the right to use, modify, reproduce, release,
perform, display, or disclose data first produced in the performance of this Agreement within the Government and otherwise including
use for Government procurement of the items covered by the data. The Government may, under a separate agreement or by modification
to this agreement, obtain any rights to use or disclose the material or data to the extent that such material or data was produced
outside the scope of the Agreement. Notwithstanding the above, as a result of this Agreement, the Government shall obtain “Unlimited
rights,” as that term is defined in DFARS 252.227-7013(a)(16) in any data generated under this agreement.

 

12.2       Marking
of Data: The Recipient is responsible for affixing appropriate markings indicating the rights of the Recipient on all data and
technical data delivered under this Agreement. Any rights that the Awardee or the Government may have in data delivered under this
Agreement, whether arising under this Agreement or otherwise, will not be affected by Awardee's failure to mark data pursuant to
this Article. Any distribution markings shall be established by the GPM and incorporated prior to distribution.

 

12.3        
Any Software (as that term is defined in DFARS 252.227-7014) developed under this agreement
shall be owned by the Recipient subject to "Unlimited Rights" (as that term is defined in DFARS 252.227-7014) held by
the Government. The Recipient shall deliver source and object code for each instance of Software developed under the agreement
in accordance with the requirements of the other deliverables under this Agreement. Use of any open source code in any Software
required to be delivered to the Government shall be subject to approval of the Government.

 

12.4       
Any Technica1 Data and Software (each term as defined under DFARS 252.227-7013) which shall
be delivered under this agreement with less than unlimited rights shall be identified in reasonable specificity and particular
rights granted (Government Purpose, Limited or Restricted (all as defined in DFARS 252.227-7013)) prior to entering into the agreement.
All other Technical Data and Software developed under funding of this agreement shall be delivered with unlimited rights as provided
for within this Article.

 

		13.	U.S. Food and Drug Administration (FDA) Regulatory Compliance

 

13.1       Good
Manufacturing Practices (GMP) Compliance. To the extent required under the Federal Food, Drug, and Cosmetic Act, the Recipient
will ensure that the manufacturing capability established under this Agreement complies with current good manufacturing practices
(cGMPs) under 21 CFR 210 and 211. The Recipient will notify the Government of any written cGMP inspection findings from the FDA
pertinent to the manufacturing capability established under this Agreement.

 

13.2       FDA
Communications. The Recipient will provide the Government with summaries of any Recipient formal meetings with the FDA and future
correspondence between Recipient and the FDA regarding the manufacturing contemplated under this Agreement and ensure that Government
representatives are invited to participate in any Recipient formal meetings with the FDA regarding topics that are material to
Recipient's compliance with the terms of this Agreement.

 

    	 	 	 

     

    

 

		14.	Termination

 

Termination and Enforcement
procedures are in accordance with 32 CFR §34.51 through §34.52.

 

		15.	Disputes

 

For any disagreement,
claim, or dispute arising under this Agreement, the parties shall communicate with one another in good faith and in a timely and
cooperative manner. Whenever disputes, disagreements, or misunderstandings arise, the parties shall attempt to resolve the issue
by discussion and mutual agreement as soon as practicable. Failing resolution by mutual agreement, the aggrieved party shall request
a resolution in writing from the AO. The AO will review the matter and render a decision in writing. Any such decision is final
and binding. In the event of a decision, within 60-calendar days of the referral for review (or such other period as agreed upon
by the parties), either party may pursue any right or remedy provided by law in a court of competent jurisdiction as authorized
by 28 U.S.C. 1491. Alternately, the parties may agree to explore and establish any Alternate Disputes Resolution procedure to resolve
this dispute

 

		16.	Reports & Distributions

 

16.1          
Monthly Progress Reports. Submitted monthly no later than the 10th of the month.
Recipient format acceptable. Electronic submission acceptable in MS Office or PDF format. Financial information shall be MS Excel
format. Monthly reports shall NOT be marked proprietary and shall have Distribution Statement C (U.S. Government and their contractors).
Each monthly report shall, at a minimum, contain the following:

 

		a.	Summary of monthly progress for the Recipient’s facilities/capabilities
associated with this effort;

		b.	Summary of progress towards established milestones for each facility/capability;

		c.	Identification of any milestone that is slipping or missed, and discussion
of path forward to bring milestone back to schedule, and impact on other milestones;

		d.	Summary of risks, discussion of potential impacts and efforts to
mitigate;

		e.	Summary of overall schedule and changes from previous month;

		f.	Financial summary of Recipient costs incurred by month to date, vouchers
submitted, and Government payments made.

 

16.2    
Quarterly-In-Process Reviews. Scheduled as needed, generally not more frequently than
quarterly, at the Recipient's facilities. Duration: eight (8) hours max. Face-to-face review of previous quarter’s activities.
Informative in nature to keep BARDA apprised of project progress and to discuss issues that may require joint resolution, such
as milestone changes, political impacts on objectives, schedule, funding.

 

16.3    
Annual Financial Status Report. (37.880)

 

16.4    
Final Report. Final Report shall not be marked proprietary, and shall have Distribution Statement
C. Final report summarizing stated objectives and the progress that was achieved in meeting those objectives; summary of risks
incurred, impacts and mitigation; quantitative discussion of needle & syringe production throughput improvements achieved;
financial summary of project; schedule summary for project, comparing original schedule to final schedule; recommendations for
path forward as applicable.

 

    	 	 	 

     

    

 

		17.	Modification of the Agreement

 

17.1       Limitation.
In no event shall any understanding or agreement, modification, change order, or other matter in deviation from the terms of this
agreement between the Recipient and a person other than the AO be effective or binding upon the Government. All such actions must
be formalized by a proper contractual document executed by the AO. The only method by which this Agreement can be modified is by
a formal, written modification signed by the AO. No other communications, whether oral or in writing, shall modify this Agreement.

 

17.2       Recommendation.
Modifications to this Agreement may be proposed by either Party. Recipient recommendations for any modifications to this Agreement,
including justifications to support any changes to the proposal (inclusive of proposal revisions, proposal appendices, and the
collaboration plan), as incorporated by reference, shall be submitted in writing to the Government PM with a copy to the AO. The
Recipient shall detail the technical, chronological, and financial impact of the proposed modification to the program. Changes
are effective only after this Agreement has been modified. The AO is responsible for the review and verification of any recommendations.

 

17.3       Unilateral
or Minor. The AO may unilaterally issue administrative Agreement modifications (e.g., changes in the paying office or appropriation
data, or changes to Government personnel identified in this Agreement, etc.). All other modifications shall be the result of bilateral
agreement of the Parties. The Government may make minor or administrative Agreement modifications unilaterally.

 

		18.	Miscellaneous

 

18.1       Security.
The Recipient shall not develop and/or handle classified information in the performance of this Agreement. No DD254 is currently
required for this Agreement.

 

18.2       Entire
Agreement. This Agreement, inclusive of the proposal, proposal revision, proposal appendices, and collaboration plan(s), constitutes
the entire Agreement between the Parties concerning the subject matter hereof and supersedes any prior understandings or written
or oral Agreement relative to said matter. In the event of a conflict between the terms of this Agreement, the terms of this Agreement
shall govern.

 

18.3       Waiver
of Rights. Any waiver of any requirement contained in this Agreement shall be by mutual agreement of the Parties hereto. Any waiver
shall be reduced to a signed writing and a copy of the waiver shall be provided to each Party. Failure to insist upon strict performance
of any of the terms and conditions hereof, or failure or delay to exercise any rights provided herein or by law, shall not be deemed
a waiver of any rights of any Party hereto.

 

18.4       Liability.
No Party to this Agreement shall be liable to the other Party for any property consumed, damaged, or destroyed in the performance
of this Agreement, unless it is due to the negligence or willful misconduct of the Party or an employee or agent of the Party.
In no event shall either Party be liable for special, incidental, or consequential damages arising from or connected with this
Agreement.

 

18.5       Non-Assignment.
This Agreement may not be assigned by any Party except by operation of law resulting from the merger of a Party into or with another
corporate entity.

 

18.6       Severability.
If any clause, provision or section of this Agreement shall be held illegal or invalid by any court, the invalidity of such clause,
provision, or section shall not affect any of the remaining clauses, provisions, or sections herein, and this Agreement shall be
construed and enforced as if such illegal or invalid clause, provision, or section had not been contained herein.

 

18.7       Force
Majeure. Neither Party shall be in breach of this Agreement for any failure of

 

    	 	 	 

     

    

 

performance caused by any event beyond its reasonable
control and not caused by the fault or negligence of that Party. If such a force majeure event occurs, the Party unable to perform
shall promptly notify the other Party and shall in good faith maintain such partial performance as is reasonably possible and shall
resume full performance as soon as is reasonably possible.

 

		18.8	Foreign Access to Technology & Domestic Manufacturing.

 

18.8.1     
Activities Abroad. The Recipient shall assure that project activities carried on outside the
United States are coordinated as necessary with appropriate Government authorities and that appropriate licenses, permits, or approvals
are obtained prior to undertaking proposed activities. The awarding agency does not assume responsibility for Recipient compliance
with the laws and regulations of the country in which the activities are to be conducted.

 

18.8.2     
Export. The Parties understand that information and materials provided pursuant to or resulting
from this Agreement may be export controlled, sensitive, for official use only, or otherwise protected by law, executive order,
or regulation. The Recipient is responsible for compliance with all applicable laws and regulations. Nothing in this Agreement
shall be construed to permit any disclosure in violation of those restrictions.

 

18.8.3    Exclusive
right to use or sell the technology in the United States must, unless the Government grants a waiver, require that products embodying
the technology or produced through the use of the technology will be manufactured substantially in the United States (37.875).

 

18.9       Publicity.
During the term of this Agreement, each Party will obtain the consent of the other Parties and the Government Program Manager before
making any press releases or public statement pertaining to the Program or to this Agreement. This consent will not be unreasonably
withheld. In addition, each Party will provide the other Parties 60-days in which to review and comment on proposed scholarly publications
or presentations. The publishing Party shall take into account any comments received, and shall remove any other Party's Confidential
Information that appears in the publication.

 

 

IN WITNESS WHEREOF, each Party has
executed this Agreement by signature of its authorized representative.

 

SIGNATURES:

 

	Recipient	 	Government
	 	 	 
	 	 	 
	[/s/ Thomas J. Shaw]	 	[/s/John Conlin]
	Signature	 	Signature
	 	 	 
	[THOMAS J. SHAW]	 	[John Conlin]
	Printed Name	 	Printed Name
	 	 	 
	[CEO]	 	Agreements Officer
	Title	 	Title
	 	 	 
	7/1/2020	 	 
	Date	 	Date

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}]]